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ABSTRACT 
 




Notch signaling is an evolutionarily conserved pathway that regulates cell-fate 
determination at various stages of development in invertebrate and vertebrate species.  The 
Notch pathway mediates juxtacrine signaling through a process termed as lateral inhibition 
by which two equipotent cells adopt distinct cell fates.  The functions of Notch have been 
exceptionally well analyzed during neurogenesis in Drosophila, particularly during eye and 
mechanosensory bristle morphogenesis.  At the onset of neurogenesis, proneural bHLH 
activators encoded by atonal (ato) or the achaete-scute complex (ASC) is expressed in 
groups of cells, called proneural clusters (PNCs) in the eye and the bristle tissue 
respectively.  From each PNC, however, only a single cell becomes the neural progenitor, 
the sensory organ precursor (SOP).  This selection is mediated through E(spl) repressors, a 
group of evolutionary conserved bHLH repressors and the terminal effectors of the Notch 
pathway.  Accumulating evidence suggest that repression of Ato/ASC by E(spl) occurs in a 
phosphorylation dependent manner.  Protein kinase CK2 phosphorylates E(spl)-M8, which 
then undergoes a conformational change and antagonizes the proneural proteins.  The work 
described in this dissertation aims to provide a more detailed understanding of the 
mechanism of neural repression by M8.  The work described in Chapter 2 provides in vivo 
evidence that multi-site phosphorylation of the C-terminal domain (CtD) of M8 may be 
involved in regulation of repressor activity.  Using phospho-mimetic variants of M8 we have 
shown that both CK2 and MAPK motif in the CtD may be modulated for the protein to exhibit 
neural repression.  Multisite phosphorylation may act as a ‘switch’ controlling the activity and 
onset of repression by M8 during neurogenesis.  The studies in Chapter 3 demonstrate a 
direct role of P-domain, a conserved phosphorylation domain of CtD, in autoinhibition model 
of M8.  The deletion variant studies provide strong evidence that the P-domain provides 
critical autoinhibitory contact with HLH and/or Orange domain to regulate repression of 
Ato/ASC.  This study provides a fundamental reinterpretation of the mechanism by which 
truncated protein, M8* encoded by m8 allele E(spl)D, that lacks the autoinhibitory domain, 
elicits precocious Ato antagonism thus interfering with first phase of Notch signaling and 
perturbing eye development.  Our studies also implicate P-domain as a target of Slmb, a 
subunit of E3 ubiquitin ligase that may give rise to ‘phosphodegron’ necessary for 
proteasomal degradation and rapid clearance of M8.  Together, the studies described in this 
dissertation provide a mechanism of M8 regulation by posttranslational regulation to elicit 
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The development of single fertilized egg into a properly formed multicellular 
(metazoan) organism is one of biology’s deepest and yet to be fully understood enigmas.  
This, in large part, reflects the necessity for multiple (combinatorial) approaches such as 
genetics, cell biology, biochemistry and biophysics, all of which are essential to understand 
how a single totipotent cell (the fertilized egg) undergoes precise and progressive changes 
in cell fates to give rise to a properly formed individual animal.  Remarkably, the 
developmental processes, which dictate the diverse cell fates, hinge upon only a handful of 
signaling pathways that are highly conserved through evolution.  These signaling pathways 
ensure that cell proliferation, differentiation, migration, apoptosis, etc., are coordinated in a 
highly precise manner during tissue formation, patterning and organogenesis.   
The five conserved signaling pathways that are key to development are Notch (N), 
Epidermal Growth Factor Receptor (EGFR), Decapentaplegic  (Dpp), Hedgehog (Hh) and 
Wingless (Wg).  Over the years, analyses in various experimental model organisms have 
outlined the core components and the architecture of these signal transduction pathways.  
Nevertheless, the challenge before us is to understand how these pathways control the 
formation of various tissues and organs, in light of the fact that they play reiterative roles 
throughout development. 
In the past few decades, remarkable progress has been made in our understanding 
of the mechanisms underlying cell-cell signaling.  It is, perhaps, not surprising that 
perturbations of these signaling pathways, either through inappropriate activation or 
inactivation, underlie various birth defects and human disease states.  In addition, it is 
becoming increasingly appreciated that polymorphisms in the components of these signaling 
pathways manifest in numerous diseases with ‘sporadic’ (tissue-specific) incidence.  It is 
therefore important to understand the precise spatial as well as temporal coordination 
between these biochemical and genetic circuits that regulates development, and this aspect 
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remains a major challenge before us.  This understanding is important to decipher tissue-
specific molecular mechanisms that underlie developmental disorders and disease states.    
Germane to the studies described in this dissertation (Chapters 2-4, see below), this 
introduction focuses on two of these signaling pathways, i.e., Notch and EGFR, and 
concludes with a discussion of the impact of phosphorylation on one (of several) effectors of 
Notch signaling, a mechanism enabling the intersection of these two pathways via post-
translational regulation.  This introduction reviews the conserved components of these 
pathways, their signaling logic, their roles in two well-studied developmental paradigms, and 
concludes with a section outlining gaps in our current knowledge.  Because these pathways 
coordinate cell fate specification throughout development, this review focuses on 
development of the nervous system in arguably the preeminent genetic model, the fruit fly 
Drosophila melanogaster.   
Studies in Drosophila have, over more than a hundred years, served as a paradigm 
and a springboard for understanding not only general principles of animal development, but 
have provided some of the most sophisticated insights into how cell signaling controls cell 
fate specification.  In part this reflects a short generation time, the low expense of 
maintaining fly stocks, a large collection of mutants, the ease of transgenic analysis, and a 
battery of molecular, genetic and immunological resources, all housed at repositories that 
are widely available to the research community.   
The Notch Pathway 
The existence of the Notch locus was revealed by the work of John S. Dexter in 
1914, upon the identification of the (name giving) mutation called ‘Notch’.  He described the 
mutation as a heritable abnormality in fruit flies, characterized by ‘notching’ of the tips of 
their wings.  Later, Thomas Hunt Morgan, through studies of mutations in Drosophila, 
identified the first allele of the Notch gene.  The nomenclature was based on the ‘notched’ 
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wing phenotype associated with the loss of wing tissue.  Although the gene was identified, 
its role in development remained largely obscure until 25 years later when David Poulson 
reported that the complete loss of Notch function resulted in embryonic lethality (Poulson, 
1937).  His work on Notch mutants was the first to associate a gene whose activity was 
specific for development in an organism.   
Subsequent studies led to the discovery of additional genetic loci that were 
necessary for proper Notch function, and the realization that aberrant Notch signaling elicits 
neurogenic phenotypes (see below).  The first detailed insights into the mode of action of 
Notch signaling came from studies in Drosophila melanogaster and Caenorhabditis elegans, 
which paved the way for better understanding the underlying mechanisms in higher 
eukaryotes, including mammals (Greenwald, 1998).   
As is the case for many genes, the number of Notch receptor subtypes differs widely 
between species.  While Drosophila has a single Notch receptor, C. elegans has two genes, 
which code for Notch receptors, LIN-12 and GLP-1 (Greenwald et al., 1983).  In contrast, 
mammals have four distinct Notch receptors, Notch 1-4 (del Amo et al., 1993; Lardelli et al., 
1994; Uyttendaele et al., 1996; Weinmaster et al., 1992).  It should, however, be noted, that 
although the number of receptors may vary amongst the aforementioned taxonomic groups, 
the basic mechanism of Notch signaling appears to be conserved (see below).  As a focus 
of the studies described in this introduction, the mechanism of Notch function will be 
discussed mainly in the developmental context of Drosophila as a model system. 
The Notch signaling pathway is involved throughout development, and regulates 
neurogenesis, myogenesis, somitogenesis, oogenesis, angiogenesis, left-right symmetry, 
formation of the cardiac and renal systems, and stem cell maintenance (Artavanis-Tsakonas 
et al., 1999; Lai, 2004; Mumm and Kopan, 2000).  More recent studies are revealing that 
Notch plays additional roles in the adult, such as its impact on the circadian rhythms.  
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Despite these diverse contexts, this pathway mediates short-range (juxtacrine) signaling 
between adjacent cells, and in an exclusively contact-dependent manner because both the 
receptor and its ligands are membrane-bound proteins.  This is underscored by the findings 
that soluble forms of the ligand Delta have the capacity to interact with the receptor, but are 
unable to mediate Notch signaling, and trigger tumorigenicity in cultured mammalian 
fibroblasts (Li et al., 2007; Urs et al., 2008).  
The Notch receptor signals through three primary modes.  The first of these, lateral 
inhibition, is the process by which Notch inhibits the default cell fate from a group of 
equipotent cells.  Consequently, lateral inhibition is necessary to ensure that from each 
cluster of equipotential cells only a single cell is allowed to maintain the primary cell fate.  
This process, the focus of my dissertation research, is discussed in greater details later in 
this introduction.  The second mode of Notch signaling is in cell fate specification, in part by 
its role in asymmetric cell division.  During asymmetric cell division, only one cell inherits a 
Notch regulator.  As a result, the two resulting daughter cells display differential Notch 
activities, which, in turn, confer distinct cell lineages/fates.  The third, boundary formation, 
occurs when a population of cells induces Notch activity in nearby cells that leads to their 
segregation into two distinct cell types.  Although classically associated with binary cell fate 
decisions, and in addition to the three modes of signaling mentioned above, Notch is also 
involved in regulation of cell proliferation, maintenance of stem cells as well as apoptosis 
(Artavanis-Tsakonas et al., 1999). 
Notch Pathway and diseases 
Given that Notch functions in diverse developmental contexts, it is perhaps 
unexpected that mutations affecting Notch signaling elicit tissue/organ-specific congenital 
abnormalities and have been linked to specific disease states.  These include diseases 
affecting various organs such as the liver, eye, kidney, vasculature and heart.  Some of the 
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inherited syndromes associated with abnormal Notch signaling include Alagille syndrome 
(Artavanis-Tsakonas et al., 1999; Gridley, 2003; McCright et al., 2002), characterized by 
organ and skeletal abnormalities, CADASIL, a disorder characterized by stroke and 
dementia (Joutel et al., 1996; Penton et al., 2012), spondylocostal dystosis, a skeletal 
abnormality (Sparrow et al., 2008), T-ALL, a T-cell acute lymphoblastic leukemia (Weng et 
al., 2004), Hajdu-Cheney syndrome, characterized by severe and progressive bone loss 
(Simpson et al., 2011), and neurodegenerative diseases such as Batten syndrome 
(Colombo et al., 2013; John et al., 2002).  In addition, defects in this pathway have been 
linked to congenital heart diseases, the hematopoietic malignancy multiple myeloma, 
multiple sclerosis, familial aortic valve disease, and other cancers (Garg et al., 2005; 
Garside et al., 2013; High and Epstein, 2008; John et al., 2002).  The broad roles of Notch 
signaling and the wide spectrum of disorders manifesting upon aberrant signaling makes it 
likely that the ‘threshold’ of Notch signaling required for its diverse tissue-specific functions is 
distinct both quantitatively and/or qualitatively, which has previously been implicated in 
studies on Notch in the Drosophila model organism (see below).  Surprisingly, some of the 
aforementioned developmental abnormalities are not fully recapitulated in the mouse model, 
suggesting that our understanding of this pathway is still incomplete.  It would seem that 
studies in both invertebrate and vertebrate model systems are needed to illuminate 
complexities in Notch signaling to impact basic and/or clinical research relevant to Notch-
related pathologies. 
Components of the Notch pathway 
The core components of the Notch pathway were identified through genetic analyses 
in C. elegans and Drosophila.  The pathway has a simple architecture where all the major 
components are conserved from Drosophila to mammals (Fig. 1A).  In Drosophila, the 
pathway consists of a transmembrane Notch receptor, its ligands Delta (Dl) or Serrate (Ser), 
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the downstream transcription factor Suppressor of Hairless (Su(H)), and the final effectors-
the basic Helix-Loop-Helix (bHLH) transcription repressors encoded by the Enhancer of split 
Complex (E(spl)C) (Delidakis and Artavanis-Tsakonas, 1991; Schweisguth and Posakony, 
1992).  The E(spl)C, which is located on the third chromosome, encodes a family of 
structurally similar bHLH repressors called Mδ, M, Mγ,  M3, M5, M7 and M8 and their 
common co-repressor Groucho (gro) (Delidakis and Artavanis-Tsakonas, 1991; Hartley et 
al., 1988; Klambt et al., 1989).  The E(spl) proteins function as repressors; this requires the 
formation of homo/hetero-dimers as well as interaction with Gro (Alifragis et al., 1997; Giebel 
and Campos-Ortega, 1997)kuzbanin.  While the mechanistic reason for the Gro-
dependency is well understood, the reason(s) why dimerization is critical to repression 
remain unclear. 
Structure of Drosophila Notch 
The Notch receptor in Drosophila is a 300 KDa single-pass transmembrane receptor 
(Fig. 1B).  The extracellular domain contains a series of Epidermal Growth Factor (EGF)-like 
repeats that are responsible for ligand binding.  The Notch receptors of different animals 
vary in the number of EGF-like repeats.  Each EGF repeat is approximately 40 residues long 
and contains six cysteine residues that are held together by three disulfide bonds (Fleming, 
1998).  The fruit fly Notch receptor has 29-36 EGF-like repeats (Fleming, 1998).  The EGF-
like repeats undergo a series of modifications via glycosylation, which are critical for 
receptor-ligand interactions and are thought to influence signaling strength.  The minimal 
region of the Drosophila Notch receptor, which is essential and sufficient for binding to the 
ligands Delta and Serrate encompass the EGF-like-repeats 11 and 12 (Rebay et al., 1991; 
Xu et al., 2005) 
Three highly conserved cysteine rich LIN-12/Notch repeats, the LNRs, follow the 
EGF-repeats.  The LNR is followed by a heterodimerization (HD) domain, which is adjacent 
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to the transmembrane domain (Tien et al., 2009).  The HD domain harbors the S2 cleavage 
site, which helps to maintain the receptor in a metalloprotease-resistant conformation 
(Gordon et al., 2007).  Together, the LNRs and the HD domains sandwiched between the 
ligand binding and the transmembrane regions of the protein comprise the negative 
regulatory region (NRR), which helps to maintain Notch in a resting confirmation (Fig. 1B).   
The cytoplasmic region of Notch contains several functional domains, represented by 
an N-terminal recombination binding protein-J associated molecule (RAM) domain (Tamura 
et al., 1995) followed by an ankyrin (ANK) domain and culminates in a long unstructured 
linker that includes a variable trans-activation domain (TAD) (Kurooka et al., 1998).  There 
are seven ANK repeats, which represent the most conserved region of the cytoplasmic 
region of the receptor.  Each ANK repeat is comprised of 33 residues and together make up 
an essential domain for Notch-receptor function.  At the extreme end of C-terminal region is 
a conserved proline/glutamic acid/serine/threonine-rich (PEST) motif that functions as a 
degradation signal and regulates receptor stability (Kopan and Ilagan, 2009; Moretti and 
Brou, 2013) (Fig. 1B). 
Notch Ligands 
Since Notch signaling is dependent on direct cell-to-cell interaction, the canonical 
ligands that bind and activate the Notch receptors are single-pass transmembrane proteins 
characterized by the presence of an N-terminal (NT) domain, followed by a DSL (Delta, 
Serrate, LAG-2) domain and a varying number of EGF-like repeats (Chillakuri et al., 2012) .  
The canonical Notch ligands belong to two classes, the Delta/Delta-like and the 
Serrate/Jagged class.  The Serrate/Jagged class of ligands has an additional domain of 
cysteine rich repeats close to the transmembrane domain.  Drosophila has two canonical 
Notch ligands- Delta and Serrate.  In contrast, there are five canonical Notch ligands in 
mammals- Jagged-1, Jagged-2, DLL1, DLL-3 and DLL-4 (D'Souza et al., 2010).     
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 Regulation of Notch Signaling 
Since the Notch pathway regulates numerous cell-fate specification events in 
metazoan animals, deregulation of signaling underlies multiple developmental disorders 
(see above).  Hence, both the timing and strength of receptor activation are key steps to 
regulate the pathway.  A host of post-translational modifications starting with ligand-
mediated activation, receptor proteolysis and target selection are critical to the regulation of 
Notch signaling.  A brief discussion on the molecular events of regulatory mechanism of 
Notch signaling is presented in the following section. 
Receptor maturation 
The Notch receptor undergoes three successive proteolytic cleavages in order to 
take the form of a mature, membrane-anchored receptor (Fig. 2).  The first proteolytic 
cleavage, which is referred to as the ‘S1 cleavage’, occurs in the trans-Golgi complex and is 
facilitated by the Furin-like convertases (Logeat et al., 1998).  The cleaved receptor is then 
targeted to the cell surface as a heterodimer composed of a Notch extracellular domain 
(NECD) and a Notch intracellular domain (NICD) held together by non-covalent interactions.  
In addition to this first proteolytic cleavage, the receptor undergoes several 
glycosylation steps in the endoplasmic reticulum and the Golgi complex before it is targeted 
to the plasma membrane as a mature receptor (Fig. 2).  The multiple EGF-like repeats of the 
extracellular domain are sites for glycolysation.  After Notch is translated, the enzyme O-
fucosyl transferase (O-Fut) adds the first fucose group to the EGF repeat 12 (Kopan and 
Ilagan, 2009).  Initially it was thought that this particular modification is essential for the 
generation of a functional receptor (Okajima and Irvine, 2002).  However, later studies in 
Drosophila demonstrated that non-fucosylated Notch was able to be trafficked properly to 
the cell membrane, interact with ligand and even able to mediate signaling (Okajima et al., 
2008; Stanley, 2007; Vodovar and Schweisguth, 2008).  Subsequently, additional 
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carbohydrate moieties are added to the fucosylated receptor, which is essential for Notch 
signaling.  In the Golgi apparatus, Fringe catalyzes the transfer of N-acetylglucosamine 
(GlcNAc) to the EGF repeats of the Notch receptor (Haines and Irvine, 2003).  Studies show 
that these glycosyl modifications alter the strength of ligand interaction with the Notch 
receptor and thus regulate its activity (as reviewed in vivo (Bray, 2006)).  For example, 
Fringe-mediated glycosylation has been shown to increase the affinity of Notch receptor for 
the ligand Delta while reducing Serrate-binding (Bruckner et al., 2000; Xu et al., 2007).  
More recently, another glycosyltransferase, RUMI, has been identified that adds O-glucose 
to specific Ser residues in the extracellular domain of Drosophila Notch (Acar et al., 2008).  
Unlike other glycosyltransferases, loss of RUMI leads to impaired Notch signaling in a 
variety of developmental contexts, indicating that it is a general regulator of the Notch 
pathway.  
Ligand Binding and Receptor Activation 
Canonical Notch signaling occurs when a ligand of the DSL (Delta and Serrate in 
Drosophila, Jagged in mammals and LAG-2 in C.elegans) family present on one cell 
interacts with Notch receptors present in the adjacent cell.  Ligand binding leads to 
activation of the receptor, which is regulated by a key proteolysis event at the S2 site within 
the LNR region.  The ADAM family of metalloproteases mediates this S2 cleavage (Fig. 2).  
In the absence of the ligand, the LNR domain sterically hinders the HD domain to occlude 
the S2 cleavage site.  Ligand binding to the receptor changes the conformation of the LNR 
region and exposes the S2 cleavage site, which is now available to ADAM proteases.  
ADAM 10 (also known as Kunzbanian in Drosophila) is responsible for cleaving Notch 
receptor at S2 site (Pan and Rubin, 1997).  Additionally, endocytosis of Notch extracellular 
domain into the ligand-expressing cell provides a mechanical force that “pulls” away the 
protective LNR repeats from the HD domain to expose the S2 site (as reviewed in (Gordon 
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et al., 2008).  This process ensures that Notch activation only takes place in two adjacent 
cells and only in the presence of ligand.  This view corroborates the finding that soluble 
ligands are insufficient to activate Notch receptor in cell culture (Sun and Artavanis-
Tsakonas, 1997).  The S2 cleavage event is followed by further proteolysis at the S3 site in 
the Notch extracellular truncation domain (NEXT) mediated by γ-secretase, which releases 
the NICD (Okochi et al., 2002).  Thus, regulated proteolytic events, ligand binding and 
endocytosis of Notch receptor domain are crucial steps in receptor activation. 
Target gene expression 
 The NICD released after the γ-secretase proteolytic event induces target-gene 
transcription.  Following its release, the NICD fragment translocates to the nucleus and 
interacts with the CSL (CBF-1 in mammals, Su(H) in Drosophila and LAG-1 in C. elegans) 
family of transcription factors via its RAM domain (Artavanis-Tsakonas et al., 1995; Bailey 
and Posakony, 1995).  This interaction switches the CSL repressors into transcriptional 
activators, which then drive the transcription of the terminal effectors of the Notch pathway, 
the bHLH E(spl)/HES repressor proteins (Fig. 2).  Prior to its activation by NICD, the CSL 
complexes with the co-repressors C-terminal binding protein (CtBP) and Groucho (Gro) and 
recruits Histone deacetylases (HDACs) to maintain E(spl)/HES in a repressed state (Barolo 
et al., 2002; Lai, 2002).  NICD and CSL combine to recruit a co-activator such as 
Mastermind (Mam) in Drosophila or Mam-like (MAML) in mammals (Petcherski and Kimble, 
2000).  Mam in turn recruits histone acetyl transferases (HATs) and p300, which stabilize 
the transcription initiation complex and activates expression of target genes (Wallberg et al., 
2002).  Subsequent phosphorylation of the NICD-CSL-MAM transcriptional complex 
downregulates the activity and ensures degradation of the NICD.  The PEST domain in 
NICD undergoes phosphorylation by CDK8 and is then targeted for proteasomal 
degradation by E3 ubiquitin ligase (as reviewed in (Kopan, 2012)).  This leads to the 
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termination of the Notch signal, and in those cases where Notch acts repeatedly, resets the 
cell for the next round of signaling.  
Eye and bristle development in Drosophila 
The functions of Notch have been exceptionally well analyzed for neurogenesis 
(Artavanis-Tsakonas et al., 1999; Mumm and Kopan, 2000), during which binary cell fate is 
determined.  The two external sensory organs of Drosophila, which have led to our 
understanding of Notch pathway in neurogenesis, include the compound eye and the 
mechanosensory bristles.  The development of these sensory organs in a precise pattern 
initiates during the larval stage and is completed during the pupal stage of development.  
The cells of these two organs are generated from the organ-specific epithelial sheet (a 
monolayer) known as the imaginal disc, which undergoes sequential specification and 
differentiation achieved by spatially and temporally restricted gene expression of various 
transcription factors.  These two sensory organs provide excellent readouts of Notch 
pathway activity as the bristles occupy invariant positions in the body and the repeating units 
of the compound eye (ommatidia or facets) are arranged in a precise hexagonal pseudo-
crystalline array (Cagan and Ready, 1989; Cubas et al., 1991; Ready et al., 1976; 
Schweisguth et al., 1997; Simpson et al., 1999).  Hence, any changes in the Notch pathway 
activity perturb the hexagonal arrangement of the ommatidia and thus the architecture of the 
eye, as well as the position and the number of bristles on the body.  Both of these defects 
result in externally visible phenotypes and even subtle perturbations in these two sensory 
organs are easily discernible by light microscopy.  This initial observation of perturbation of 
neurogenesis can be followed by immunohistochemistry on the eye-antennal disc or the 
wing disc, parts of which give rise to the adult eye and thorax, respectively.  
Notch Signaling and Lateral Inhibition 
At the onset of neurogenesis, proneural bHLH activators encoded by atonal (ato) or 
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the genes of the achaete-scute complex (ASC) are expressed in groups of cells, called the 
proneural clusters (PNCs) (Heitzler et al., 1996; Jarman et al., 1995; Jarman et al., 1994).  
The activities of these proneural proteins drive the formation of the PNCs, in which all cells 
have somewhat equal potential to adopt the neural fate (Dambly-Chaudiere and Vervoort, 
1998).  From each PNC, however, only a single cell will go on to become the neural 
progenitor, the sensory organ precursor (SOP) (Fig. 3).  This restriction of the SOP-fate to a 
single cell from a PNC has been termed lateral inhibition (Simpson, 1990).  During this 
process, one of the cells of PNC gains an advantage over the others by producing higher 
levels of Ato/ASC, and thereby expresses higher levels of Dl.  This asymmetry in Dl levels 
elicits activation of Notch in the adjacent cells of the PNCs (the non-SOPs).  Specifically, 
activation of Notch results in the cleavage and nuclear translocation of it’s intracellular 
domain (NICD), where it associates with and activates Su(H) leading to the E(spl) 
transcription (Bailey and Posakony, 1995) (Fig. 3).  The E(spl) repressors along with Gro 
then antagonize Ato/ASC to restrict the SOP fate in all but one cell of a PNC.  In fact, Gro is 
a corepressor essential for a large group of bHLH proteins; those encoded by the E(spl)C, 
Deadpan and Hairy (Paroush et al., 1994).  Consistent with this model, decreased Notch 
pathway activity results in the emergence of multiple SOPs from each PNC.  This 
supernumerary SOP specification results in a rough eye and ectopic and closely juxtaposed 
bristles. 
Notch Signaling during Drosophila eye development 
The remarkably precise hexagonal geometry of the compound eye of Drosophila has 
afforded an ideal system to understand the role of different signaling pathways in pattern 
formation.  The Notch pathway is central to Drosophila eye development.  The compound 
eye of Drosophila is composed of ~800 ommatidia arranged in a hexagonal lattice (Fig. 4).  
Each ommatidium is composed of eight photoreceptors (R1-R8- the retinula cells), twelve 
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accessory non-neuronal cells such as pigment cells and cone cells, and an interommatidial 
bristle (IOB).  During the third larval stage (instar), eye morphogenesis initiates at the 
posterior margin of the eye-antennal disc, a monolayer neuro-epithelium that is the 
progenitor of the retina.  Retinal neurogenesis starts with the specification of the R8 
photoreceptors (Jarman et al., 1994).  R8 specification occurs in a moving wave of 
differentiation, called the morphogenetic furrow (MF) (Fig. 4), which is discernible in 
unstained tissue due to constriction of the cells mediated by localized polarization of actin.  
R8 specification is a critical and essential first step during eye morphogenesis as it 
subsequently recruits all other cell types in the assembling ommatidia.  In “null mutation” of 
ato (ato1) no R8’s are specified and the eye is lost. Because of this vital role played during 
ommatidial formation, R8 cells are referred to as the ‘founding’ photoreceptors.  While R8 
selection occurs within the MF, all secondary photoreceptor recruitment occurs posterior to it 
(Wolff and Ready, 1991).  The movement of the MF from the posterior margin of the eye 
disc to its mid-point (its final limit) occurs in 48 hrs.  Thus analyses of the mid-late L3 stage 
eye disc provide a broad temporal window to understand the mechanisms of specification of 
various cell types during neurogenesis. 
During R8 ontogeny, Notch serves biphasic roles.  At stage-1, the anterior margin of 
the MF, cells begin to express low levels of ato cell autonomously to form the ‘Ato-stripe’. 
(Fig. 4)  This proneural enhancement step is induced by Notch activation (Baker et al., 
1996).  Ato then dimerizes with Daughterless (Da), eliciting high levels of ato transcription.  
This process called ato auto-activation generates pre-R8 clusters, the intermediate groups 
(IGs) with somewhat equal potential to become an R8.  At stage-2/3 of the MF, a single R8 
is non-autonomously selected from each IG by lateral inhibition (Fig. 4).  During this 
process, Notch mediates expression of E(spl) proteins, which repress Ato in all but a single 
cell of an IG (Ligoxygakis et al., 1998).  By stage-4, single patterned R8s emerge and these 
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cells are marked by the sustained expression of the Ato target gene senseless (sens) whose 
expression is first observed at the three-cell Ato positive cluster (Nolo et al., 2000; Pepple et 
al., 2008).  After this point in R8 ontogeny, Sens expression continues to be maintained in 
all differentiated R8s throughout the developing eye disc.  Posterior to the MF, R8s emerge 
in a precise phase-shifted manner, such that R8s of one column are out of phase to those in 
the adjacent column.  This alternating spacing (patterning) is vital for the hexagonal 
architecture of the adult eye.  Consistent with this view, targeted overexpression of Ato in 
the MF elicits the specification of supernumerary R8s, and results in a rough eye phenotype 
(White and Jarman, 2000).  The R8s then systematically recruit surrounding uncommitted 
cells as the R2/R5, R3/R4, R1/R6 cells, concluding with the specification of the R7 cell 
(Cagan and Ready, 1989) (Fig. 4).  All of these cell fate specifications also involve Notch 
signaling (Fanto and Mlodzik, 1999; Tomlinson and Struhl, 2001). 
Notch Signaling during Drosophila bristle development 
The external sensory organs of Drosophila also include mechanosensory bristles of 
the peripheral nervous system.  The two types of bristles that have been studied extensively 
to understand neurogenesis are the machrochaetes and the interommatidial bristles (Fig. 5).  
The number and position of these bristles are invariant and are regulated by Notch-
mediated lateral inhibition (Hartenstein and Posakony, 1990).  Each bristle contains four 
distinct types of cells; a socket cell, a sheath cell, a shaft cell and a neuron. 
Each bristle arises from a single precursor cell termed the sensory organ precursor 
(SOP), which is selected from a group of equipotent cells, the PNCs.  Although SOP 
specification occurs at third instar larval stage, bristle morphogenesis does not begin until 
the pupal stage.  Unlike the eye, however, expression of ASC proneural activators is 
independent of Notch signaling and instead depends on pre-pattern factors (Calleja et al., 
2002).  The SOP is selected from the PNC by lateral inhibition in a manner akin to the R8 
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cell.  In this case, the cell expressing highest level of proneural activators encoded by the 
Achaete-Scute gene complex in response to pre-pattern factors is destined to become the 
SOP and in turn initiates lateral inhibition via the E(spl) repressors in the adjacent cells of 
the PNC by activating Notch (Artavanis-Tsakonas et al., 1999; Castro et al., 2005; Giebel 
and Campos-Ortega, 1997).  The events after SOP selection are however different from 
those following R8 specification.  The SOP undergoes two asymmetric cell divisions to 
generate the four distinct cell types characteristic of the bristle.  The SOP at first forms the pI 
neuroblast, which then divides asymmetrically to give rise to the pIIa and pIIb cells.  
Asymmetric division of the pIIa cells generates external socket and shaft cells, which form 
the external structures of the bristle (Fig. 5).  The pIIb cell, on the other hand, divides 
asymmetrically to give rise to a glial cell and the third order precursor called the pIIIb cell.  
Asymmetric division of pIIIb cell gives rise to the two internal cells of the bristle, the neuron 
and the sheath cell (Fig. 5). 
A body of genetic evidence supports the reiterated roles of Notch signaling in bristle 
development.  For example, loss of Notch function prior to SOP selection leads to the 
specification of extra SOPs from each PNC.  In adult flies, each of these extra SOPs goes 
on to form a complete bristle, which manifest as ectopic and closely spaced bristles 
(Campos-Ortega, 1998; Skeath and Carroll, 1991).  On the other hand if Notch function is 
lost after SOP selection, the stoichiometric sister cell fates become skewed resulting in split 
bristles or missing bristles (Bray, 1997; Campos-Ortega, 1997).  A split bristle reflects a 
defect in the asymmetric division of the pIIa cell, which transforms a socket cell into a shaft 
cell.  On the other hand, a missing bristle can be a manifestation of either the loss of SOP, 
itself, or a defect in the asymmetric division of SOP.  A defect in the asymmetric division 
gives rise to two pIIb cells, which result in the specification of two sets of neurons and 
sheath cells.  Because the shaft and socket cells, the external components of the sense 
organ are missing, this manifests as a missing bristle. 
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E(spl)-C complex and bHLH repressors 
 
E(spl)-bHLH repressors are the terminal effectors of the Notch inhibitory pathway 
during eye and bristle development.  These proteins repress Ato/ASC during the time of 
lateral inhibition and restrict neural competency to a single cell of the PNC.  The E(spl) 
complex (E(Spl)C), encompasses ~60 Kb region on the 3rd chromosome and encodes 7 
structurally similar bHLH proteins (Mγ, Mδ, Mβ, M3, M5, M7 and M8) (Fig. 6), four Bearded 
family member (BFM) proteins (Mα, M6, M4 and M2), one protease inhibitor, kazal-m1 and 
the distal, non-bHLH protein Gro (Delidakis and Artavanis-Tsakonas, 1991; Lai et al., 2000; 
Wurmbach et al., 1999).  Gro protein is known to physically interact with the E(spl)-bHLH 
repressors and is needed for their function (Paroush et al., 1994).  Recent studies have 
shown that the BFM proteins function as inhibitors of Neuralized, an E3 ubiquitin ligase, 
which is necessary for ubiquitinylation and subsequent endocytosis of the Notch ligands, 
Delta and Serrate (Bardin and Schweisguth, 2006; De Renzis et al., 2006).  This step is 
necessary for ligand activation. 
The E(spl)-locus is conserved across 12 Drosophila species and reveals remarkable 
molecular synteny with respect to both the number of homologs and their position relative to 
one another (Fig. 6).  Given estimates of evolutionary distances between these 12 species 
(Beverly and Wilson, 1984), it appears that the E(Spl)C locus has remained largely 
unchanged for over 50 myr.  In addition, the conservation of consensus sites for several 
protein kinases in specific members presents a unique opportunity to better understand how 
these proteins are regulated during development (see below).  Initial studies revealed that 
over-expression of any E(spl) protein elicited loss of bristles and the SOPs (Giebel and 
Campos-Ortega, 1997; Nakao and Campos-Ortega, 1996).  Consequently, these proteins 
have been considered to be functionally redundant, a view that also extends to their 
mammalian homologues, the HES proteins.  It has been argued that 'redundancy' is an 
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oversimplification, as the order of the seven E(spl) genes and their direction of transcription 
is conserved over ~60 myr of Drosophila evolution (Maier et al., 1993).   
Over the years, several studies have sought to identify the functional domains and 
the mechanism of neural repression by E(spl) proteins.  All E(spl) bHLH proteins have in 
order from the N-terminus, a basic domain (DNA binding), an HLH domain (dimerization), a 
second HLH region, the Orange domain (interaction with Ato/ASC) and a C-terminal WRPW 
motif (Gro-binding) (Fig. 7).  While these domains are highly conserved between individual 
E(spl) members, their length and/or sequence heterogeneity is largely confined to the C-
terminal domain (CtD), the region between Orange and WRPW.  This region was therefore 
thought to not be important for repressor activity, but studies conducted in our lab are 
revealing that the CtD plays an important role in regulating repression in vivo.  Specifically it 
was shown that the CtD of M5, M7 and M8 harbors a highly conserved site for 
phosphorylation by the kinase CK2 (Fig. 7), one that mediates both E(spl)-CK2 interactions 
and results in their phosphorylation.  These studies thus raised the possibility that these 
three E(spl) members are regulated by post-transcriptional modification (Trott et al., 2001). 
Although much time has been spent investigating the mechanism of neural 
repression by E(spl) members, no universal mode of action has emerged.  It was initially 
proposed that E(spl) proteins bind to specific DNA elements called the N-box sequence in 
target genes, recruit Gro and elicit their repression (Tietze et al., 1992; Van Doren et al., 
1994).  However, it was subsequently shown that deletion of N-box from ASC enhancers 
failed to impair repression in vivo.  Moreover, the enhancers of Ato, a gene vital for eye 
development and whose expression pattern is refined by E(spl)-M8, lacks any credible N-
box like sequence, suggesting alternative mechanisms underlie repression by these 
proteins.  A more recent study proposed that E(spl) proteins directly interact with enhancer-
bound ASC/Atonal proteins and regulate repression via this protein-tether mechanism 
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(Alifragis et al., 1997; Giagtzoglou et al., 2003; Gigliani et al., 1996).  These interactions are 
thought to involve the Orange domain of E(spl) proteins, a proposal validated by 
biochemical and yeast-two hybrid assays, where E(spl) members have been shown to 
(physically) interact with ASC members, Atonal and their co-activator Daughterless (Dawson 
et al., 1995; Giebel and Campos-Ortega, 1997; Gigliani et al., 1996). 
Role of E(spl) members in eye and bristle development 
Initial studies involving SOP and bristle development have led to the notion that 
transcription and accumulation of E(spl) proteins, was by itself, sufficient for neural 
repression (Giebel and Campos-Ortega, 1997; Nakao and Campos-Ortega, 1996).  In 
contrast, studies in the eye development rendered different results.  In the developing eye, 
the loss of E(spl) did in fact compromise lateral inhibition and result in excess R8 
specification, but ectopic expression of M5, M7 and M8  did not elicit a dominant loss of R8 
cells (Ligoxygakis et al., 1999).  The inactivity of M5 and M7 may reflect the fact that these 
two members of the E(spl) family are not expressed at this stage of eye development and 
are thus dispensable for R8 specification and/or patterning (Cooper et al., 2000).  However, 
endogenous M8 is expressed in the MF during R8 specification and its mutation, the E(spl)D 
allele, has also been shown to severely affect R8 patterning and eye formation (see below).   
Based on these distinct developmental outcomes it was suggested that M5 and M7 must be 
qualitatively different than M8, a contention, which remained largely unresolved. 
The dominant allele E(spl)D was first identified in 1956 based on its ability to impair 
eye formation when combined with the split allele of Notch (Nspl) (Tietze et al., 1992; 
Welshons, 1956, 1965).  It was in fact the ‘enhancement’ of the split eye defect of the Notch 
allele, that led to the nomenclature as ‘E(spl)’.  E(spl)D codes for a truncated protein 
referred to as M8*, which lacks 56 residues of the CtD.  Despite not binding to Gro as it 
lacks the WRPW motif, M8* displays exacerbated repression of Atonal, thereby blocking R8 
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birth and eye development.  Because M8* lacks the WRPW motif and hence has no ability 
to bind its co-repressor, it has been suggested that E(spl)D is a ‘Gro-independent 
hypermorph’ (Nagel et al., 1999).  Surprisingly, such a developmental defect could not be 
recapitulated simply by removal of the WRPW motif from a full-length M8.  This paradox was 
addressed by the late Dr. Campos-Ortega, who presciently proposed that the CtD of M8 
may have a regulatory influence on E(spl)-M8 activity.  However, the nature of this 
regulation remained unknown until the finding that this region between Orange domain and 
WRPW motif is a target for phosphorylation (Karandikar et al., 2004).  It was then that the 
biochemical mechanism of repression by E(spl)-M8 began to become more clear. 
Regulation by E(spl) repressors is phosphorylation dependent 
A role for CK2 emerged from the cloning of m7 transcript based upon its interaction 
with CK2 in multiple (yeast) two-hybrid screens.  Follow up studies revealed that CK2 
interacted with only three of the seven E(spl) proteins, M7, M8 and M5.  This interaction was 
mapped to the CtD region, which uncovered a highly conserved consensus for CK2 (Trott et 
al., 2001).  This motif in the case of E(spl)-M8 is S159DCD (Ser-Asp-Cys-Asp).  Subsequent 
to these studies, it has been found that HES6, the mammalian homolog of E(spl)-M8, 
harbors a similar phosphorylation motif that is also modified by CK2 in vitro (Gratton et al., 
2003b).  These results raise the possibility that E(spl) phosphorylation by CK2 is a key 
regulatory step in Notch signaling during lateral inhibition. 
Follow-up studies investigated the role of CK2 in repression by M8, using variants 
that replace the CK2-phospho acceptor Ser159 with Asp or Ala.  The Ala variant (M8S159A) 
renders the protein non-phosphorylatable whereas the Asp modification (M8S159D) mimics 
the hyper-phosphorylated state.  Overexpression of wild type M8 led to loss of 
interommatidial bristles (IOBs) and the macrochaetes (MCs) but failed to elicit any 
ommatidial defects.  Also, no eye defects were seen with the non-phosphorylatable isoform, 
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M8-S159A.  However, overexpression of M8-S159D elicited strong loss of R8s and a severe 
reduction of the eye (Karandikar et al., 2004).  The R8/eye defects of M8SD are virtually 
identical to those of M8* (Nagel et al., 1999) which lacks the CtD and its resident CK2 site.  
Furthermore, yeast two-hybrid assays reveal that M8* and M8-S159D interact with Ato with 
equal strength, whereas M8 or M8-S159A do so only weakly.  It was thus proposed that the 
CtD region likely autoinhibits the Orange domain, previously implicated in Ato binding (Jafar-
Nejad et al., 2003).  Phosphorylation displaces this 'cis' interaction permitting repression 
(Fig. 7).  Consequently, the truncation of CtD in M8* removes this regulatory region, thereby 
bypassing autoinhibition and resulting in a protein that constitutively binds to Ato.  If so, it 
would suggest that CK2 regulates the lateral inhibition mediated by M8.  Consistent with 
these findings, targeted knockdown of CK2 elicits supernumerary R8s from the IGs in the 
developing retina, and to supernumerary MCs and SOPs in the bristle lineage (Bose et al., 
2006).  These results reveal a key role for CK2 in the control of E(spl) activity during Notch-
mediated lateral inhibition, and that this kinase regulates E(spl)/Notch functions in broader 
contexts.  In a similar manner, CK2 modifies HES6 and this post-translational modification 
(PTM) is essential for the formation of a HES6-HES1 complex.  Thus the role of CK2 in 
promoting protein-protein interactions between two classes of bHLH proteins appears to be 
highly conserved.  However, the developmental significance of the HES6 phosphorylation 
and the regulated formation of HES6+HES1 dimer in humans remains unexplored.  
The expression of M8 or M8SD in the bristle lineage elicited a loss of MCs with equal 
severity, a stark contrast with respect to the results seen in the eye (Karandikar et al., 2004).  
The difference in results between eye and bristle led to the suggestion that role of CK2 
might be dispensable in ASC antagonism during bristle development, but that it plays a 
critical role in eye development.  It is possible that the absence of a role for CK2 in the 
bristle formation reflects a limit phenotype, a function that is not discernible by the approach 
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of ectopically expressed proteins. 
The ‘autoinhibition’ Paradox 
In line with the autoinhibition model, one would expect that both M8SD 
(phosphomimetic variant) and M8* (lacking the CtD) should be constitutively active 
repressors of Ato and should enable activity to be evaluated at three critical stages of R8 
birth.  If anything, their repressive activity should be maximal at stage-1, where Ato levels 
are the lowest, as compared to that at stage-2/3 of the MF, where Ato levels are at the 
highest and have achieved a ‘threshold’ sufficient to drive birth of the R8s.    However, 
contrary to this prediction, the dominant eye defects of M8* and M8SD have been found to 
be MF stage-specific.  It appears that the dominant eye defects of M8SD are stage-2/3 
specific where lateral inhibition refines R8s from PNCs.  In contrast, M8* elicits a severely 
reduced eye only at stage-1 of the MF, but fails to exhibit any activity at stage-2/3.  If 
phosphorylation by CK2 was necessary and sufficient to overcome the autoinhibited state, 
M8SD should have also elicited loss of R8s/eye upon expression at stage-1 in a manner 
akin to M8*.  The inactivity of M8SD at stage-1 therefore raises the possibility that, while 
important, CK2 is insufficient to activate M8 on its own.  If so, are other regulatory enzymes 
involved?   
The possibility of M8 undergoing secondary modifications was hypothesized given 
that the P-domain conserves a number of Ser residues in addition to that which is modified 
by CK2 (Ser 159).  This clustering of Ser residues within the CtD is not only conserved in 
Drosophila M5/7, but also in murine and human HES6.  In the case of HES6, secondary 
phosphorylation by MAPK, an effector of Epidermal Growth Factor Receptor (EGFR) 
signaling, has been demonstrated in cell lines, but how this regulates HES6 activity during 
development has not been reported.  Interestingly, upstream of the CK2 site in Drosophila 
M8 lies a PxSP motif, which meets the strict consensus for modification by MAPK.  Although 
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the developmental consequences of phosphorylation of HES6 by MAPK are unknown, the 
possibility arises that multisite phosphorylation by CK2 and MAPK could be essential for 
regulation of repression by Drosophila E(Spl) proteins.  If M8 activity were to require both 
CK2 and MAPK, it would establish that EGFR signaling potentiates Notch pathway activity 
and that these two signaling pathways do not always act in an antagonistic manner, and 
provide important insights into the complex roles of EGFR signaling during eye development 
(see below).  
Protein Kinase CK2 
CK2 is a conserved Ser/Thr protein kinase present ubiquitously in all eukaryotes.  It 
is a highly conserved kinase that plays critical roles in diverse cellular and biochemical 
events such as gene expression, cell cycle progression, cell signaling, DNA replication and 
repair, transcription, translation and apoptosis (as reviewed in (Meggio and Pinna, 2003)).  
The kinase was first isolated and identified from rat liver extracts in the laboratory of Eugene 
Kennedy (Burnett and Kennedy, 1954).  The protein was aptly named ‘protein 
phosphokinase’ for its ability to catalyze the addition of phosphate (from ATP) to Ser/Thr 
residues on the protein casein.  However, casein is not a natural (physiological) target of 
CK2 and thus no biological relevance could be established behind this phosphorylation 
effect.  In 1955, seminal work from Edmond Fischer and Edwin Krebs’ lab demonstrated that 
phosphorylation is an important biochemical step for regulating enzyme activity.  
Specifically, they showed that glycogen phosphorylase is activated by cAMP-dependent 
protein kinase (PKA) (Fischer and Krebs, 1955).  This discovery has been the foundation of 
studies identifying and characterizing protein kinases present in biological systems, and 
efforts to analyze their roles in regulating diverse cellular functions such as cell division, 
DNA replication, transcription and translation, animal development, etc. 
During the purification process of Casein Kinase in Jolinda Traugh’s laboratory, two 
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forms of the enzyme were identified based on their order of elution in column 
chromatography and consequently these two activities were named Casein Kinase I and II 
(Hathaway and Traugh, 1979).  Following purification, antibodies specific for mammalian 
CK2 were generated which demonstrated cross-reactivity with homologous enzymes from 
Drosophila and worms (Dahmus et al., 1984).  Furthermore, it was shown that the CK2α 
subunit from Drosophila, human and worms can functionally substitute for one another 
(Bidwai et al., 1992; Padmanabha et al., 1990).  Together, these observations indicate that 
CK2α is universally conserved in both structure and function in all eukaryotes. 
Biochemistry of CK2 
 The CK2 holoenzyme is a hetero-tetramer that is composed of two catalytic (α) 
subunits and two regulatory (β) subunits (Glover et al., 1983; Padmanabha and Glover, 
1987).  The α-subunit displays the catalytic activity and can utilize either ATP or GTP as a 
substrate (Glover et al., 1983).  The catalytic activity of monomeric CK2α is stimulated by 
the regulatory β-subunit, which modulates substrate recognition and provides stability to the 
holoenzyme (Cochet and Chambaz, 1983).  The mammalian enzyme contains two isoforms 
of the catalytic subunit (α and α’) that are encoded by two distinct genes whereas a single 
gene specifies the regulatory β-subunit.  
 When compared to other protein kinases, CK2 can utilize either ATP or GTP as 
phosphoryl donor to phosphorylate Ser/Thr residues (Dahmus et al., 1984; Glover et al., 
1983; Hathaway et al., 1980).  CK2 preferentially targets acidic substrates and recognizes a 
unique consensus sequence at its target site.  This consensus sequence is S/T-D/E-x-D/E, 
in which the acidic residues at positions n+1 and n+3 are rate limiting for phosphorylation 
(Kuenzel and Krebs, 1985; Kuenzel et al., 1987).  Additional acidic residues at the N- and C-
terminus of this microdomain further enhance phosphorylation activity of CK2 towards the 
target protein.  The effect of the acidic residues in the microdomain can be biochemically 
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mimicked by pSer/pThr, which generates hierarchical sites thus increasing the likelihood of 
progressive phosphorylation by CK2.  The most extreme example of hierarchical 
modification is Nopp140, a protein that is progressively modified by CK2 at 72 sites (Meier 
and Blobel, 1992). 
CK2 and its role in development 
 Since its discovery in 1953, a range of targets for CK2 has been identified by 
genetic, biochemical and computational studies.  The kinase has been thought to play an 
essential role in different branches of cell biology, which includes cell-cycle control and cell 
proliferation, circadian rhythmicity, cell signaling and animal development and even in 
learning and memory.  Its role as a cell cycle regulator was first observed when the 
stimulation of mammalian cells in culture with the mitogen Epidermal Growth Factor (EGF) 
elicited oscillations in the levels and activity of CK2 (Sommercorn et al., 1987).  Moreover, a 
synchronous oscillation in CK2 activity was seen with G1 to S and G2 to M phase transitions 
in the mammalian cell cycle, results since corroborated by the isolation and analysis of 
temperature-sensitive alleles of yeast CK2 (Hanna et al., 1995; Rethinaswamy et al., 1998).  
In another study, it was shown that deletion of the genes encoding the catalytic subunit of 
yeast CK2 (CKA1 and CKA2) resulted in a cell death, and cells depleted of CK2 displayed a 
‘pseudomycelial’ or ‘Shmoo’ morphology, a classic cell division cycle (CDC) phenotype 
reflecting the uncoupling of cell growth from cell division in budding yeast (Padmanabha et 
al., 1990).  The most unique role of CK2 is perhaps displayed during Theileriosis, a B- and 
T-cell lymphoproliferative disorder in cattle.  It was the pioneering work of Dr. Ole-MoiYoi, a 
veterinarian in Kenya, which displayed that cattle exhibiting the symptoms of this disease 
invariably harbored the parasitic protozoa, Theileria parva, in their circulatory system.  His 
work subsequently demonstrated that this parasite preferentially infects B- and T-cells and 
overexpresses a unique secretory from of CK2, which accumulates in the cytosol of the host 
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cell (ole-MoiYoi, 1995; ole-MoiYoi et al., 1993).  This parasite-derived CK2, which bears 
striking similarity with the normal (mammalian) variant of the kinase, likely deregulates the 
normal control of the cell cycle, which then elicits the development of lymphomas.   
In addition, CK2 has been shown to associate with mitotic spindles and the 
centrosomal apparatus (Yu et al., 1991).  It also interacts with vital regulators of cell division 
and replication checkpoint controls and targets a number of proto-oncogene-derived 
proteins such as Myc, Myb, Fos and Jun (Luscher et al., 1989; Winkler et al., 2000).  
Besides its role in development of tumors, CK2 has been closely linked to metastasis, for 
which substantial efforts are underway to design specific inhibitors of this enzyme and 
suppress the detrimental effects. 
Given the vital role of CK2 in diverse biological processes, significant efforts have 
been made to characterize the large number of targets of CK2.  High throughput techniques 
and availability of genomic sequences have made it possible to identify a large number of 
targets for CK2.  These interactions include proteins involved in various types of cellular and 
biological functions such as DNA replication, transcription and translation, cell polarity and 
development, cytoskeleton architecture and cancer (reviewed in (Meggio and Pinna, 2003)).  
Therefore, the loss of CK2 elicits cell lethality in all unicellular and metazoan organisms. 
Drosophila CK2 
 Drosophila CK2 was first purified from embryos and similarly to its mammalian 
counterpart was shown to be a tetramer, composed of two α subunits and two β subunits 
(α2β2 holoenzyme).  A single CK2α gene located on the 3rd chromosome encodes the 
catalytic subunit, whereas the regulatory subunit is encoded by CK2β gene on the X 
chromosome (Bidwai, 2000).   
To date, two spontaneous mutations of the CK2α gene has been identified based on 
their ability to elicit defects in the circadian clock.  These are known as Timekeeper  (Tik), 
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and its partial revertant, called TikR (Lin et al., 2002).  Tik harbors two substitutions, M161K 
and E165D.  The M161K substitution is located within the ATP-binding pocket, thus interfering 
with the enzymatic activity of CK2 (Rasmussen et al., 2005).  Accordingly, Tik is 
homozygous lethal and the lethality is manifested at first instar larval stage.  The second 
substitution, E165D lies in a highly conserved motif, H E165NRKL, which mediates physical 
interaction between human CK2α and protein phosphatase PP2A (Heriche et al., 1997).  
Although thought to be a silent mutation at first because it involved a conservative 
replacement, the importance of E165D mutation was soon realized as it impairs 
downregulation of phosphatase activity.  Thus, Tik has been aptly suggested to be a ‘double 
hit’, inactivating CK2 activity on one hand and enhancing PP2A activity on the other hand 
(Kunttas-Tatli et al., 2009). 
TikR was identified as a spontaneous revertant allele, based on its ability to partially 
compensate for the circadian clock defects in Tik/+ animals.  In addition to the two mutations 
already present in the Tik allele, TikR harbors an R242G (Arg to Gly) substitution and a 
deletion of seven internal amino acids (234-240).  Consequently, TikR is also homozygous 
lethal, manifesting its lethality at first instar stage (Lin et al., 2002).  Studies indicate that 
TikR is insoluble, which points to defects in protein folding mechanism, a defect not seen 
with Tik.  Moreover, unlike wild type CK2α or mutant Tik, the TikR protein does not interact 
with CK2β, an interaction, that is essential for tetrameric holoenzyme assembly (Kunttas-
Tatli et al., 2009).  These observations led to the view that Tik integrates into and ‘poisons’ 
the endogenous holoenzyme, thus compromising its activity.  In contrast, since TikR is 
unable to assemble into the holoenzyme, it shows a revertant behavior in context to the 
circadian clock where halve dosage of CK2 (TikR/+) may still be sufficient to maintain near-
normal functionality of circadian rhythms.  Apart from clock defects, neither Tik nor TikR, 
display any overt developmental abnormalities in heterozygous condition, indicating that the 
28 
 
residual levels of CK2 are sufficient for normal developmental functions of the cells/tissues. 
Recently, a third allele of CK2α, CK2MB0047 has been described that harbors a 
transposable minos element in the 5’UTR (Bellen et al., 2004).  Unlike, Tik or TikR, 
CK2MB0047 homozygotes manages to complete all three larval stages, but manifest in lethality 
at the pupal stage.  This indicates that CK2MB0047 is a hypomorph and consistent with its 
characteristic fails to elicit any eye or bristle defects in heterozygous state. 
An allele of CK2β (andante) also displays clock defects.  The mutant protein fails to 
form a stable holoenzyme in vivo.  However, in vitro analysis with the human variant of 
andante challenges this idea, and the mechanism underlying the clock defect in Drosophila 
remains unresolved (Rasmussen et al., 2005).  Homozygous andante flies are viable, 
indicating that it is a hypomorphic allele (Akten et al., 2003). 
The Epidermal Growth Factor Receptor (EGFR) Pathway 
The Epidermal Growth Factor Receptor (EGFR) Pathway is a conserved pathway 
that regulates diverse processes critical for metazoan development, ranging from cell 
proliferation and survival to cell-fate specification to differentiation (Doroquez and Rebay, 
2006).  Reflecting this importance, several efforts have been made to understand the signal 
transduction and the underlying mechanism of each member involved in this pathway 
(Yarden, 2001).  The pathway has been studied extensively in Drosophila, C.elegans and 
mammalian cell lines and several computational models have been analyzed to understand 
its dynamics (Schoeberl et al., 2002; Voas and Rebay, 2003; Wassarman et al., 1995). 
EGFR Receptor and Ligands 
EGFR is a transmembrane receptor belonging to the family of receptor tyrosine 
kinases.  These receptors are anchored in the cell membrane and contain an extracellular 
ligand-binding domain, a short hydrophobic trans-membrane region, and an intra-
cytoplasmic tyrosine kinase domain.  In Drosophila and C.elegans, the receptor is coded by 
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a single gene namely Drosophila EGF receptor (DER) and let-23 respectively.  Mammalian 
EGFR consists of four members, which include EGFR/ErbB1/HER1, ErbB2/HER2/Neu, 
ErbB3/HER3 and ErbB4/HER4 (Yarden, 2001).     
In the Drosophila system there are four activating ligands- Spitz (Spi), Keren (Krn), 
Gurken (Grk) and Vein (Vn) and one secreted inhibitor Argos (Aos) (Neuman-Silberberg and 
Schupbach, 1993; Reich and Shilo, 2002; Rutledge et al., 1992; Schnepp et al., 1996).  Spi, 
Krn and Grk are all synthesized as membrane-bound precursors and are subsequently 
cleaved by a Rhomboid family protease to be secreted (Urban et al., 2002).  The membrane 
protein Star plays a role in the EGFR pathway by trafficking the ligand precursors from the 
ER to the Golgi where they can be cleaved by Rhomboid for secretion (Lee et al., 2001).  
Spi is the principle ligand activating the DER pathway in the majority of developmental 
contexts, including Drosophila eye morphogenesis, while Krn and Grk are less frequently 
involved (Freeman, 1994).  Vn belongs to the Neuregulin family and is utilized in a number 
of tissues such as in the wing, muscle attachment sites and distal leg regions (Campbell, 
2002; Yarnitzky et al., 1997).  The inhibitory ligand, Aos is unique to Drosophila so far, as no 
mammalian/worm homologue has been identified.  DER signaling leads to enhanced aos 
expression, which suggests that it plays a negative feedback loop role, thus regulating 
EGFR pathway output (Wasserman et al., 2000).  Given the import of this negative feedback 
loop, it remains enigmatic why a mammalian counterpart has remained unidentified. 
In mammals the ligands that regulate ErbB receptors can be separated into two main 
groups.  ‘EGF agonists’ activate EGFR and Neuregulins that bind ErbB3 and ErbB4 (Yarden 
and Sliwkowski, 2001).  There are no known ligands for ErbB 2 and it is thought to play a 
role in EGFR pathway by forming heterodimers with other ligand-activated ErbB family 
members.  In C.elegans, the ligand for EGFR is Lin-23.  It is a soluble TGF-α-like ligand 




EGFR pathway activation 
In the absence of ligand, EGFR is monomeric and the cytoplasmic tail shows no 
kinase activity.  When ligand binds to the extracellular domain of the receptor, it induces 
receptor homo- or hetero-dimerization, which leads to subsequent activation of the intrinsic 
tyrosine kinase domain.  The cytoplasmic tail of the receptor undergoes ‘trans-
phosphorylation’ where one receptor monomer phosphorylates the Tyrosine residues of the 
other binding partner.  The phosphorylated residues of the dimerized receptor serve as 
docking sites for downstream signaling proteins.  The activated receptors also mediate 
signals by phosphorylating target proteins.  EFGR hetero-dimerization is a unique feature of 
the mammalian system (Schlessinger, 2000).  In contrast, Drosophila and C. elegans exhibit 
only homodimerization due to the presence of only one isoform of EGFR.  Receptor 
heterodimerization has been attributed to diversity and specificity of EGFR function and to 
signal output. 
MAPK pathway 
Among all the different signaling pathways activated by EGFR, the MAPK pathway is 
a widely studied and critically important signal transduction mechanism for regulating cell 
proliferation and cell survival.  The pathway works via a three-tier phosphorylation cascade 
in which the terminal (effector) kinase, MAPK, is activated upon phosphorylation by mitogen 
activated protein kinase (MAPKK), which in turn is activated upon phosphorylation by 
MAPKKK.  Activated MAPK either phosphorylates proteins in the cytoplasm or in the 
nucleus, targeting various transcription factors and thus regulating transcription (Reiser et 
al., 1999).  To date, six different MAPKs have been identified in mammals; extracellular 
regulated kinases (Erks 1/2, Erks 3/4, Erks 5, Erks 7/8), Jun N-terminal kinase (JNK) 1/2/3 
and p38 isoforms α/ β/ γ (Erk 6) and δ (Krens et al., 2006; Kyriakis and Avruch, 2001; 
Schaeffer and Weber, 1999).  Drosophila expresses all three subgroups of the MAPK; 
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Rolled (Rl), Basket (Bsk) and p38a/b.  Rolled and Basket are Erk and JNK homologs, 
respectively, whereas p38a/b are homologs of p38.EGFR signaling in Drosophila 
The EGFR pathway in Drosophila begins with Spi binding to the extracellular domain 
of DER.  Ligand binding activates DER, which undergoes autophosphorylation and in turn 
activates a downstream GTPase called Ras (Seger and Krebs, 1995).  Activated Ras then 
activates Raf1 (MAPKKK), which then phosphorylates and activates the dual specificity 
kinase MEK (MAPKK).  The kinase MEK then phosphorylates MAPK (ERK) at Tyr and Thr 
residues within the activation loop (Zhang et al., 1995).  Dual-phosphorylated MAPK 
(dpERK) targets both cytoplasmic and nuclear proteins, phosphorylating at Ser/Thr/Tyr 
residues (Reiser et al., 1999).  In Drosophila, the nuclear targets of dpERK include ETS 
transcription factors Pointed (Pnt) and Anterior open (Aop), also referred to as Yan (O'Neill 
et al., 1994; Rebay and Rubin, 1995).  Pnt, a transcriptional activator and Yan, a repressor, 
both harbor an ETS-DNA binding domain, by virtue of which they compete for the regulatory 
regions of the downstream transcriptional targets.  Upon DER signaling, dpERK 
phosphorylates Yan, which then undergoes nuclear export and subsequent degradation.  
dpERK simultaneously phosphorylates Pnt converting it into a strong activator, which then 
activates transcriptional targets previously repressed by Yan (Brunner et al., 1994; O'Neill et 
al., 1994).  This dual regulation thus confers bimodality of EGFR signaling in flies. 
Negative regulators of the EGFR pathway also play a key role in fine-tuning the 
complex signaling profile of this developmental pathway.  In Drosophila, high level EGFR 
activity upregulates transcription of the inhibitory ligand Aos (Golembo et al., 1996).  Aos 
inhibits EGFR signaling without directly interacting with the receptor.  Instead, Aos binds to 
the Spi, thus sequestering it.  The Spi-Aos complex does not bind to the receptor and as 




Role of EGFR in Drosophila eye and bristle development 
From specification of the MF, to the specification of the different photoreceptors and 
the their roles in ommatidial spacing, EGFR plays a critical role either working cooperatively 
or antagonistically with Notch. 
The EGFR pathway has been implicated in the initiation of the MF, upstream of Hh 
and Dpp signals.  It has been proposed that the EGFR pathway plays a role in both furrow 
birth (formation of the posterior margin) and furrow reincarnation (formation of MF along the 
lateral margin) during Drosophila eye development (Kumar and Moses, 2001).  A study 
conducted by Kumar and Moses suggests that during birth of the MF, the EGFR pathway 
signals to Notch which in turn signals to Hh (Hedgehog).  EGFR-mediated expression of Hh 
induces photoreceptor differentiation, which, in turn, induces elevated EGFR signaling and 
activation of the downstream effector Pnt.  Activated Pnt confers regulation on Hh, thus 
establishing a positive feedback loop which facilitates continued forward progression of the 
MF (Rogers et al., 2005).  During the furrow reincarnation step EGFR signals to Notch 
which, in turn, activates the Dpp pathway (Kumar and Moses, 2001).  Dpp is expressed 
along the posterior and lateral margins of the developing retina, its ectopic expression leads 
to the formation of precocious furrows along the anterior margins (Chanut and Heberlein, 
1997). 
It has been suggested that EGFR positively regulates expression of the homeo 
domain protein Rough (ro) in the MF.  Ro is expressed in the PNC, which induces Ato 
expression in all but R8 cells, consequently selecting a single R8 cells.  Thus EGFR 
indirectly controls the singling out process of R8 cells by maintaining Ro expression in the 
PNC (Dominguez et al., 1998).  
The EGFR pathway plays an important role in machrochaete morphogenesis in 
Drosophila, and accordingly hypomorphic mutations of the Egfr gene have been shown to 
elicit the loss of several notum machrochaete with varying frequencies (Clifford and 
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Schupbach, 1989).  In mosaic clones of hypomorphic Egfr alleles, both the absence and the 
duplications of macrochaetes have been observed (Diaz-Benjumea and Garcia-Bellido, 
1990).  The overexpression of the inhibitor of EGFR pathway, Aos, in the PNC results in the 
loss of essentially all macrochaetes.  It has been suggested that only a subset of bristles 
require DER signaling.  The notum machrochaetes, whose positions are invariant, are 
sensitive to lowered dosage of DER signaling and fail to be specified in a precise manner, 
the microchates are much more resistant to the lowering of the DER signaling (Culi et al., 
2001).  This is perhaps an outcome of the invariant nature of the microchaetes, which are 
organized in density patterns instead of being specified at fixed positions in the notum. 
Suspected role of EGFR signaling during R8 specification in Drosophila 
While there is abundance of evidence for the contribution of MAPK to retinal 
determination, the role of the EGFR pathway in R8 selection is unclear.  Analysis of the 
EGFR allele Ellipse (Elp) revealed loss of intermediate group or R8 cells, suggesting a role 
of Egfr in R8 specification (Lesokhin et al., 1999; Yang and Baker, 2001).  Elp also 
exacerbated the effects of the Notch allele, Nspl (Baker and Rubin, 1992), which by itself 
exhibits a gain-of-function behavior affecting R8 selection.  Moreover, ectopic activation of 
EGFR pathway by several mechanisms was reported to enhance Ato expression and 
specify ectopic R8s (Yang and Baker, 2001).  It has also been suggested that the transient 
expression of the dominant–negative EGFR, DERDN, blocks R8 specification and proneural 
cluster formation.  In addition, ectopic expression of Aos leads to the loss of Ato expression, 
which, in turn, results in the loss of and aberrant spacing of R8s (Spencer et al., 1998).  
Consistently, reducing Aos activity results in the formation of ectopic R8s, although 
disruption of ommatidial patterning is not very severe in such a case (Freeman et al., 1992; 
Spencer et al., 1998). 
Investigators have detected dp-ERK, an active form of the MAPK, in the cytoplasm, 
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several hours after EFGR activation (Kumar et al., 1998).  This activated MAPK staining was 
absent in EGFRnull clones, suggesting that dp-ERK accumulation is a direct downstream 
effect of EGFR signaling and neither an artifact nor can be attributed to the activation of 
other RTKs such as Sevenless (Lesokhin et al., 1999).  The cytosolic hold on this kinase 
would lead one to think that its established targets, the ETS family transcription factors Pnt 
and Yan/Aop, are not the canonical targets of this pathway.  Indeed if one looks at data from 
the laboratory of Nicholas Baker, in clones of Pnt (Yang and Baker, 2003) there is no 
evidence of defects in R8 spacing, suggesting that in this particular context the EGFR 
pathway could well be used in a non-canonical manner, where the Egfr effects are not 
realized within the nucleus. Based on these observations it has been suggested that EGFR 
may cooperate with the Notch pathway to restrict R8 fate to a single cell within a PNC during 
lateral inhibition. 
Preface to chapters 2-4 of this dissertation 
 The studies described in Chapter 2 and 3 of this dissertation seek to address the 
molecular mechanism of repression by M8 during R8 selection and patterning.  These 
studies should determine the contribution of EGFR/MAPK signaling in Ato repression by M8.  
The proposed role of EGFR in R8 selection has heretofore lacked a molecular target. The 
characterization of M8 as a mediator of EGFR pathway during R8 specification will address 
this unresolved question. 
In chapter 2, the studies described involve site-specific (Asp/Ala) variants of M8 to reveal 
the role of CK2 and MAPK in repression of Ato.  The findings, based on both gain- and loss-
of-function analyses, are consistent with the possibility that the two regulatory inputs, CK2 
and MAPK, modulate Notch activity through sequential phosphorylation of the CtD of the 
M8.  Our studies indicate that both modifications of the Ser residues in the P-domain are 
necessary to relieve the autoinhibited state of M8 and elicit its repressor activity during 
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neurogenesis.  Moreover, studies using spatially controlled expression of M8 variants 
suggest that CK2 is likely to play a more permissive role, whereas MAPK controls when and 
where M8 is activated.  Such a control mechanism through two kinases may control both the 
amplitude and duration of active M8 within the MF.  
In chapter 3, I more directly evaluate the role of the P-domain in autoinhibition.  I have 
generated deletion constructs, which either lack the CK2 motif, or the MAPK motif or the 
entire P-domain.  The experiments described in this chapter of the dissertation address the 
important question whether CK2 and MAPK phosphorylation are required purely (solely) at 
the level of intramolecular protein contact(s) and whether dual modification of these two 




        
Fig. 1: Core components of Notch pathway and Drosophila Notch Receptor.  
(A) The core components of Notch pathway as seen in different species.  (B) Schematic 






Fig. 2: Schematic representation of Notch signaling pathway.   
The primary steps in Notch activation involve glycosylation and cleavage by Furin (S1 
cleavage) followed by receptor maturation.  When ligand binds to the Notch receptor of an 
adjacent cell, the receptor undergoes two consecutive proteolytic cleavages, releasing 
NICD, which translocates to the nucleus and mediates transcription of the E(spl)/HES 






Fig. 3: Lateral inhibition during R8 specification in Drosophila eye development.  
Notch signaling plays a role in lateral inhibition, as seen between adjacent cells in the 
proneural cluster (PNC).  This inhibitory signal is contact-dependent and is mediated by the 
ligand Delta, which appears on the cell surface of one cell and binds to the Notch proteins 
on the neighboring cells.  The future R8 cell (orange) is shown to express high levels of 
Delta, which binds to the Notch receptor in the adjacent non-R8 cell (white) and triggers 
inhibitory Notch signaling.  The pathway terminates with expression of E(spl) repressors 































Fig. 4: Compound eye of Drosophila and mechanism of R8 specification and 
patterning.   
SEM shows the structure of the adult compound eye in Drosophila, which is an array of 
precisely positioned cluster of unit eyes known as the ommatidium.  (A) The bold arrow 
indicates the progression of the morphogenetic furrow (MF, blue vertical stripe) from the 
posterior to the anterior part of eye disc.  (B) Eye disc showing the expression pattern of the 
proneural protein Atonal, which is expressed in a broad stripe ahead of the MF, but 
posteriorly resolves into single cells that become R8’s.  (C) A schematic representation of 
the MF showing the biphasic role of Notch during R8 specification.  Inset below represents 
the sequential recruitment of the secondary photoreceptors following R8 specification. 




Fig. 5: Bristle morphogenesis in Drosophila.   
(A) The position of the Macrochaetes (MCs - yellow asterisk) and the microchaetes (mcs – 
black arrow) on the nota of the fly body.  (B) Position of the interommatidial bristles (IOBs – 
yellow asterisk) on the eye of fruit fly.  (C) Bristle morphogenesis requires Notch mediated 
lateral inhibition during SOP selection followed by asymmetric division of the SOP for 







Fig. 6: E(spl) C locus and its molecular synteny across 12 Drosophila species.   
(A) Schematic representation of the genomic organization of E(spl) locus.  It encodes for 
seven E(spl) repressors and the co-repressor Groucho.  E(spl)- mδ, mγ and m8 are 
expressed in the MF (green boxes).  Proteins encoded by E(spl)- mγ, m5, m7 and m8 have 
conserved CK2 sites (highlighted in red).  (B) Molecular synteny of E(spl) locus across 12 
Drosophila species.  Note (red arrow pointing at centromere) that there is a complete 
inversion of the locus for six Drosophila species, although the order of the transcription units 


















Fig. 7: Structure of M8 and autoinhibition model of M8 regulation.   
(A) Schematic representation of the functional domains of E(spl)M8.  Conserved Ser 
residues in the phosphorylation domain (P-domain) of the CtD in M8, M5, M7 and human 
and murine HES6 proteins.  The yellow boxes represent the MAPK and CK2 motifs.  
Additional conserved Ser residues are also highlighted (red).  (B)  Autoinhibition via CtD 
may block dimerization via HLH (blue) or Ato binding via Orange domain.  Phosphorylation 
of M8 by CK2 regulates antagonism of Ato/ASC in N+ flies, whereas M8* requires Nspl 





Fig. 8: Structure of CK2 holoenzyme and the alleles of Drosophila CK2α subunit.  
(A) Schematic representation of the CK2 holoenzyme.  It is a tetramer made up of α 
(catalytic) and β (regulatory) subunits.  Ribbon diagram of the human CK2 holoenzyme (as 
described in (Niefind et al., 2001)).  The two catalytic subunits (magenta) assemble on the 
two regulatory (yellow and blue) subunits.  (B) The three alleles of Drosophila CK2α subunit 
– CK2MB0047, Tik and TikR and their corresponding lesions are indicated. 




Fig. 9: Components of the Drosophila EGFR pathway.   
Ligand binding activates EGFR receptor on the cell surface, which undergoes 
autophosphorylation and activates downstream effector molecules.  The downstream 
signaling cascade activates MAPK, which translocates to nucleus and phosphorylates 
Pointed (Pnt) and Yan.    
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CHAPTER 2: The conserved MAPK site in the Notch effector E(spl) M8 controls 






Enhancer of split (E(spl)) M8, an effector of Drosophila Notch signaling, is activated 
by protein kinase CK2 and inhibited by the phosphatase PP2A.  CK2 targets a region of M8 
that conserves additional Ser residues.  One of these Ser residues meets the strict 
consensus for MAPK, a kinase that mediates the effects of Epidermal Growth Factor 
Receptor (EGFR) signaling.  The studies described here reveal an important role for the 
conserved MAPK site on M8.  Our analysis, using Ala/Asp mutations, suggests that together 
CK2 and MAPK ensure that M8 repression of Ato occurs in a timely manner and at a precise 
stage (stage-2/3) of R8 birth.  M8 repression of Ato is mitigated by halved EGFR dosage, 
and this effect requires an intact MAPK site.  Accordingly, variants of M8 with a 
phosphomimetic Asp at the MAPK site exhibit earlier (inappropriate) activity against Ato at 
stage-1, where a positive feedback-loop is needed to raise Ato levels to a threshold 
sufficient to specify the R8 fate.  Using deletion variants, we demonstrate that both kinase 
sites likely contribute to ‘cis’-inhibition of M8.  This key regulation by CK2 and MAPK is 
bypassed by the E(spl)D mutation encoding the truncated protein M8*, which inhibits Ato at 
stage-1 of R8 birth.  Finally, we provide evidence that PP2A likely targets the MAPK site, 
and that regulation of M8 by MAPK appears to be dispensable during bristle development.  
Together, our studies reveal that multi-site phosphorylation controls timely onset of M8 
repressor activity in the eye, but does not appear to play a role in the bristle.  The high 
conservation of the CK2 and MAPK sites in the insect E(spl) proteins M7, M5 and Mγ, and 
their mammalian homologue HES6, suggest that this regulation may enable E(spl)/HES 
proteins to orchestrate repression by distinct tissue-specific mechanisms, and is likely to 





The external sensory organs of Drosophila include the compound eye and the 
mechanosensory bristles which are patterned and established during the larval and pupal 
stages of development.  The remarkably precise hexagonal geometry of the compound eye 
of fruit flies has afforded an ideal system to understand pattern formation during 
development.  The compound eye of Drosophila is composed of ~800 light sensing 
repetitive units (ommatidia) arranged in a hexagonal lattice.  Each ommatidium is composed 
of eight photoreceptors (R1-R8), twelve accessory cells and an interommatidial bristle (IOB).   
During the third larval stage (instar), eye morphogenesis initiates at the posterior 
margin of the eye disc, a monolayer neuro-epithelium that is the progenitor of the retina.  
Retinal neurogenesis starts with the specification of the R8 photoreceptors in a moving 
wave of differentiation, called the morphogenetic furrow (MF) (Jarman et al., 1994).  While 
R8 selection occurs within the MF, all secondary photoreceptor recruitment occurs posterior 
to it (Wolff and Ready, 1991).  The temporal nature of the MF thus represents a 48-hour 
window, encompassing retinal neurogenesis. 
R8 specification occurs in the MF and involves biphasic Notch signaling.  At stage-1, 
the leading edge of the MF, Notch induces the expression of the proneural bHLH activator 
Atonal (Ato) at a low level to form the ‘Ato-stripe’.  Heterodimers of Ato and Daughterless 
(Da) then elicit high levels of ato transcription.  This process, called ato auto-activation, 
generates neural competency in a group of equipotent cells termed proneural clusters 
(PNCs).  At stage-2/3 of the MF, the future R8s of the PNC express high level of ligand 
Delta (Dl), which interact with the Notch (N) receptors of the adjacent cells (Simpson, 1990).  
Activated N receptors undergo cleavage and release the intracellular domain (Nicd), which 
then translocate to the nucleus.  In the nucleus, Nicd interacts with Suppressor of Hairless 
(Su(H)) and elicits transcription of bHLH repressors encoded by the Enhancer of split 
48 
 
Complex (Eslp(C) (Bailey and Posakony, 1995; Delidakis and Artavanis-Tsakonas, 1991; 
Lecourtois and Schweisguth, 1995).  The E(spl) proteins, in a complex with Gro, refines Ato 
expression to a single cell of the PNC (Ligoxygakis et al., 1998; Paroush et al., 1994).  This 
phase of inhibitory Notch signaling where R8 cell fate is restricted to one cell in the pre-
cluster is known as ‘lateral inhibition’.  By stage-4, single patterned R8s emerge and 
differentiate as the R8 photoreceptors by sustaining expression of the Ato target gene 
senseless (sens).  The R8s then systematically recruit surrounding uncommitted cells as the 
R2/R5, R3/R4, R1/R6 cells, concluding with the specification of the R7 cell (Cagan and 
Ready, 1989). 
Given that lateral inhibition is critical for proper structure and patterning of the eye 
and E(spl) proteins are central to this process, several genetic studies have sought to 
analyze their modes of action (Giebel and Campos-Ortega, 1997; Knust et al., 1987; Nakao 
and Campos-Ortega, 1996; Preiss et al., 1988; Ziemer et al., 1988).  Although these studies 
were the first of their kind to establish the role of E(spl) proteins in eye patterning, it has 
been difficult to identify their exact roles because Eslp(C) encodes seven bHLH proteins 
with similar functional domains.  To complicate things further, individual mutations affecting 
each transcriptional unit have been unavailable, making it impossible to study their individual 
effects on pattern formation.  Initial studies revealed that over-expression of any E(spl) 
protein elicited loss of bristles and the SOPs (Giebel and Campos-Ortega, 1997; Nakao and 
Campos-Ortega, 1996).  Consequently, these proteins have been considered to be 
functionally redundant (Cooper et al., 2000), a view that also extends to their mammalian 
homologues, the HES proteins.  It has been argued that 'redundancy' is an 
oversimplification, as the order of the seven E(spl) genes and their direction of transcription 
is conserved over ~60 myr of Drosophila evolution (Maier et al., 1993).  
Three E(spl) members, M8, Mγ, Mδ, are expressed in the eye tissue during R8 
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selection but only ectopic Mδ elicited loss of R8s (Ligoxygakis et al., 1998).  It therefore, 
raises the possibility that these three E(spl) members are ‘qualitatively different’, but the 
underlying nature of this difference remained unresolved.   
 The central role of M8 during R8 selection is underlined by the R8 and eye defects of 
the unique dominant allele E(spl)D (Welshons, 1956).  In the presence of a gain of function 
Notch allele, Nspl, the E(spl)D allele disrupts retinal histogenesis.  It is this interaction that led 
to the original identification of the E(spl) locus.  E(spl)D encodes a truncated protein called 
M8*, which lacks 56 C-terminal residues (CtD) (Nagel et al., 1999; Tietze et al., 1992).  It 
was observed that ectopic M8*, but not full length M8, mimics the R8 defects of E(spl)D, 
indicating that the truncation results in a hyperactive protein.  The hyperactivity of M8* 
indicated that the CtD region is likely to regulate repressor activity of M8.  Studies in our 
laboratory, identifying the phosphorylation of M8 at its CtD by protein kinase CK2 provided 
key insights into the mechanisms underlying hyperactivity of M8* and thus regulation of 
repression by M8 (Trott et al., 2001).   
 CK2 phosphorylates M8 at Ser159 in the CtD.  Replacement of the CK2 phospho-
acceptor (Ser159) with a phosphomimetic Asp residue (M8-S159D) was found to elicit 
exacerbated loss of R8s and the eye with a potency akin to E(spl)D (Kahali et al., 2009a; 
Karandikar et al., 2004; Nagel et al., 1999).  Moreover, M8-S159D interacts with Ato with a 
binding strength equal to that of M8*.  Consequently it was proposed that the CtD 
autoinhibits full length M8 (Kahali et al., 2010a).  Phosphorylation displaces this intra-
molecular interaction permitting repression of Ato.  The truncation of M8* would bypass this 
regulation, implicating CK2 as a regulator of R8 selection through the activation of M8 
(Karandikar et al., 2004).  Accordingly, loss of CK2 in the imaginal disc of an otherwise wild 
type flies compromises lateral inhibition and elicits the specification of excess R8s from the 
IGs (Bose et al., 2006).   
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 The eye defects of the CK2-mimic M8-S159D are specific to stage-2/3 of the MF.  If 
CK2 were to solely control auto-inhibition, the expression of M8-S159D at stage-1, where 
Ato levels are the lowest, should have also elicited loss of R8 and the eye.  The inactivity of 
M8-S159D at stage-1 raises the possibility that CK2 may be insufficient to activate M8. If so, 
are other regulatory enzymes involved?  This possibility is likely given that the CK2 site in 
M8 is located in a region termed the P-domain that conserves a number of other Ser 
residues.  The P-domain is conserved in all M8 isoforms through ~60 million years of 
Drosophila evolution.  The Ser residues represent consensus motifs for phosphorylation by 
MAPK, CK1 and GSK3.  The high conservation of Ser residues, in addition to those 
modified by CK2, raises the possibility that M8 may be regulated by multisite 
phosphorylation.  Although no R8 defects have been described for mutations in CK1 and 
GSK3, numerous lines of evidence implicate EGFR signaling in R8 selection.  This pathway 
is also known as the Drosophila EGF receptor or DER pathway in Drosophila. 
 Studies from several groups have shown the presence of active MAPK 
(diphosphorylated ERK) in IG cells at stage-2/3 of the MF (Kumar et al., 2003; Kumar et al., 
1998; Spencer et al., 1998; Yang and Baker, 2003); this staining is lost in the clones of 
EGFR (Lesokhin et al., 1999) demonstrating that other RTKs such as Sevenless, are not 
responsible for activating MAPK.  Moreover, in DER clones the IGs do not resolve into 
single R8 and excess R8s are specified (Baonza et al., 2001).  An identical effect is seen in 
eye disc lacking the downstream effectors of the DER pathway, i.e., Ras and Raf (Yang and 
Baker, 2001).  In the canonical DER pathway, activated MAPK targets the nuclear 
transcription factors Pointed (Pnt) and Yan.  Surprisingly, unlike DER clones, extra R8s are 
not seen in clones lacking pointed (Yang and Baker, 2003).  In addition, activated MAPK in 
the IGs is held in the cytosol (Kumar et al., 2003), a location that should prevent its targeting 
of nuclear-only Pnt or Yan (Shilo, 2003).  The possibility remains that the role of DER/MAPK 
is to target and activate M8 allowing for repression of Ato.  In a sense, DER may therefore 
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control when and where M8 activity manifests. 
 The studies we describe here indicate the importance of MAPK motif in M8 repressor 
activity.  Site-specific as well as deletion mutants of CK2 and MAPK sites of M8 have been 
used to demonstrate the role of these two kinase motifs during R8 specification.  Our studies 
indicate that modifications at both sites appear to be necessary for M8 repressor activity and 
modification at the CK2 site is epistatic to phosphorylation at the MAPK site.  If M8 activity 
were to require both CK2+MAPK, it would establish that EGFR signaling potentiates Notch 
pathway activity; that these two signaling pathways do not always act in an antagonistic 




M8 repressor activity in the developing eye requires multi-site phosphorylation 
The birth of patterned R8s in the MF (Fig. 1A) hinges upon timely repression of Ato 
by E(spl) proteins.  The importance of E(spl)-M8 is supported by the severely reduced eye of 
the m8 mutation E(spl)D (encoding M8*) and that of a variant (M8-S159D) harboring Asp in 
place of Ser159, the target for protein kinase CK2 (Fig. 1B).  The latter studies, which 
utilized Gal4 drivers with expression at distinct stages of R8 ontogeny (Fig. 1A), reveal that 
phosphorylation of Ser159 is key to Ato repression (Fig. 1B) (Karandikar et al., 2004).  The 
reduced eye of M8-S159D is seen with scaGal4 and 109-68Gal4, whose stage-2/3 
expressivity (Fig. 1A) correlates to endogenous E(spl) genes.  The difference in severity of 
the reduced eye (Fig. 1B) reflects stronger strength of scaGal4, as compared to 109-68Gal4 
(Doherty et al., 1997).  No reduced eye is seen with wild type M8 (Fig. 1B), a finding 
previously shown by others (Giebel and Campos-Ortega, 1997; Nagel et al., 1999).   It was 
proposed that CK2 converts ‘cis’-inhibited M8 to a state active for binding and repressing 
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Ato.  This regulation is bypassed by the Asp at the CK2 site (M8-S159D), or upon loss of the 
CtD and the P-domain in M8*, the product of E(spl)D (see schematic in Fig. 1B).   
Follow-up studies suggest that activation of M8 by CK2 is an oversimplification.  
First, unlike its reduced eye at stage-2/3, expression of M8-S159D at stage-1 (hH10Gal4) is 
without effect (Fig. 1B).  This stage-1 inactivity was unexpected as Ato levels are lowest at 
this point of R8 birth (Fig. 1A), and should have been most sensitive to repression by (non 
‘cis’-inhibited) M8-S159D.  This inactivity does not reflect weak strength of hH10Gal4, as 
expression of M8* with this Gal4-driver elicits a near complete loss of the eye (Fig. 1B, and 
see refs).  Second, we have recently reported that the reduced eye of M8-S159D is strongly 
mitigated by increased activity of the phosphatase PP2A (Bose et al., 2014).  Because 
replacement of Ser159 with Asp should have rendered M8 refractory to phosphatase 
activity, we hypothesized that multi-site phosphorylation of the P-domain (Fig. 1B) controls 
M8 repression of Ato. 
To analyze multi-site phosphorylation of M8, we adopted site-specific (ϕC31) 
integration to enable controlled comparisons of Ala/Asp variants at multiple kinase sites.  
We chose the ϕC31 site at 68E, one of ‘moderate’ expressivity.  This site was chosen, 
because random insertions of M8-S159D elicit a near complete loss of the eye (Fig. 1B), 
which we reasoned is likely to be a limit phenotype and thus unlikely to reveal the 
contributions of phosphorylation of sites in addition to CK2.  Accordingly, scaGal4 
expression of M8-S159D (from ϕC31-68E) elicits a reduced eye of moderate severity (Fig. 
1C, E).  No eye defect is seen upon expression of M8-S159D with hH10Gal4, or in relevant 
controls (Fig. 1D, E).  Thus the M8-S159D insertion at ϕC31-68E qualitatively mimics 
random insertions, described previously.   
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E(spl)-M8 harbors a highly conserved consensus site for MAPK 
The P-domain of M8 contains four Ser residues, which are invariant in 12 Drosophila 
species and the stalk-eyed fly Teleopsis (Fig. 2A) that diverged ~100 MYA.  The flanking 
Ser residues meet the strict consensus for CK2 and MAPK, and the intervening six residues 
contain two additional phosphoacceptors.  Importantly, the CK2 and MAPK sites are 
conserved in mammalian HES6, but with three distinctions.  First, an insertion of six 
additional residues widens the spacing of the CK2 and MAPK sites.  Second, this insertion 
includes tandem Asp residues (DD motif, Fig. 2A), which can often bypass the need for 
phosphorylation.  Third, mouse HES6 replaces a Ser with Pro in the linker, suggesting that 
this site may not be vital to regulation of human HES6.   
The full analysis of the contributions of all four Ser residues of M8 with Ala and/or 
Asp would necessitate ≥64 variants, beyond the scope of a single manuscript.  We focused 
on the MAPK site, as this protein kinase mediates the effects of EGFR signaling, a pathway 
implicated in the birth of patterned R8s, and because murine HES6 is modified by CK2 and 
MAPK (Belanger-Jasmin et al., 2007; Gratton et al., 2003b).  The developmental roles of 
HES6 phosphorylation remain unknown.  Given the divergence time between Dipterans and 
mammals (Fig. 2A), we hypothesized that MAPK is important in controlling M8 activity. 
We previously reported that a variant refractory for CK2 (M8-S159A) does not mimic 
wild type (unmodified) M8, but elicits a rough eye due to dominant-negative (DN) activity 
(Karandikar et al., 2004).  We thus refrained from mutating the MAPK site on a backbone 
with an Ala at the CK2 site.  A backbone of wild type M8 or M8-S159D (Fig. 2B) was used to 
generate three Ala/Asp variants of Ser151, the MAPK site.  M8-S151A+S159D is refractory 
to MAPK but mimics CK2, and should reveal if these two kinases cooperate to control M8 
activity or act redundantly.  M8-S151D is a MAPK-mimic that should render M8 activity 
independent of EGFR/MAPK signaling.  The third, M8-S151D+S159D, is a dual kinase 
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mimic that should render M8 activity independent of CK2 and MAPK.  In a yeast two-hybrid 
assay, all variants interact robustly with Groucho (Gro, Fig. 2B), which is essential for M8 
repressor activity in vivo.  
An intact MAPK site is essential for activity of the CK2 mimic M8-S159D 
We first compared the activity of M8-S159D (CK2 mimic) and M8-S151A+S159D 
(refractory to MAPK but mimics CK2).  Unlike M8-S159D, no reduced eye was seen upon 
expression of M8-S151A+S159D with scaGal4 (compare Fig. 3A to Fig. 1C).  Two findings 
argue against a defective construct or instability of M8-S151A+S159D protein in vivo.  This 
variant inhibits development of the IOBs (data not shown) and strongly elicits the loss of 
macrochaetes (MC’s) and microchaetes (mc’s) with potency similar to the CK2 mimic M8-
S159D (Fig. 3B, C).  These effects on the MC’s/mc’s reflect expression of scaGal4 in 
proneural clusters that give rise to these bristle types.  Thus an intact MAPK site is essential 
for M8 repressor activity in the eye, but not the bristle. 
We next tested the MAPK-mimic (M8-S151D) and the dual-kinase mimic (M8-
S151D+S159D).  However, both variants elicited embryonic lethality when expressed with 
scaGal4.  Lethality was seen even in crosses conducted at 18C where Gal4 activity is often 
attenuated (Fig. 3D).  To circumvent this problem, we used 109-68Gal4, a weaker stage-2/3 
driver.  Flies expressing all four M8 variants were viable and elicited a range of eye defects.  
Expression of the CK2 mimic (M8-S159D) elicited a rough eye and loss of the IOBs (Fig. 
4A), but did not significantly reduce eye size (compare to Fig. 1C).  This lack of a reduced 
eye reflects moderate expressivity from the ϕC31-68E site (Fig. 1B, C) combined with the 
weaker driver 109-68Gal4.  The rough eye of M8-S159D was abrogated by the introduction 
of an Ala at the MAPK site (Fig. 4D), although loss of IOBs remained (data not shown).  In 
contrast, the MAPK-mimic (M8-S151D) or the dual-kinase mimic (M8-S151D+S159D) 
elicited a strong loss of the eye with almost equal severity (Fig. 4B, C) demonstrating the 
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importance of the MAPK site in controlling M8 activity.  No eye/IOB defects are seen in 109-
68Gal4/+ flies or the four M8-transgenic lines on their own (inset in Fig. 4E).  As 109-68Gal4 
is active in PNCs that give rise to bristles, we also quantified loss of the MCs.  Although 
attenuated in severity when compared to results with scaGal4 (Fig. 3B, C), expression of all 
four variants with 109-68Gal4 elicited MC loss with similar potency (Fig. 4A’, B’, C’, D’).  The 
lack of effects on the mcs reflects weaker strength of 109-68Gal4.  Together, these studies 
reveal that the MAPK site is important for M8 activity in the eye, but not the bristle. 
M8 variants with a modified MAPK site perturb R8 specification 
We next determined if M8 variants perturb birth of R8s and secondary 
photoreceptors by staining for Senseless (Sens) and ELAV, respectively.  The reduced eye 
upon expression of the CK2-mimic M8-S159D with scaGal4 (Fig. 1C) reflects strong loss of 
R8s (Sens+ cells), and many of the R8s that emerge from the MF poorly sustain Sens 
expression, and thus inefficiently recruit secondary (ELAV+) photoreceptors (for example 
see Fig. 7A’).   
As the expression of MAPK variants with scaGal4 was lethal (Fig. 3D), we used 109-
68Gal4 to enable analysis of all M8 variants.  Consistent with the wild type eye, 109-
68Gal4/+ flies display proper Sens expression/maintenance and ELAV staining akin to wild 
type discs (data not shown).  Expression of the CK2 mimic M8-S159D elicited the weakest 
effects (Fig. 5A) wherein a few R8s failed to maintain Sens expression and poorly recruited 
ELAV+ cells.  Consequently, a few regions of the eye disc are devoid of closely juxtaposed 
ELAV clusters (circled region in Fig. 5A’), as compared to control discs.  These R8s are 
likely removed by apoptosis, a default fate for uncommitted cells, contributing to the ‘rough 
eye’ of M8-S159D expressing flies (Fig. 4A).  No such defects are seen with M8-
S151A+S159D (Fig. 5B,B’), confirming that an Ala residue at the MAPK site renders M8 
inactive in the eye even in the presence of an activating mutation at the CK2 site.  In 
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contrast, discs expressing the MAPK mimic M8-S151D or the dual-kinase mimic M8-
S151D+S159D display the inconsistent maintenance of Sens levels along the AP axis in a 
greater proportion of R8s (Fig 5C, D).  Many of these R8s also poorly recruit secondary 
photoreceptors, such that numerous clusters contain less than (the normal) 1Sens+7ELAV 
cells, characteristic of discs from 109-68Gal4/+ or wild type flies (Fig. 5C’,D’).  Moreover, 
significant regions of the eye disc altogether lack Sens+Elav clusters, a result consistent 
with the reduced eye.  Thus the reduced eyes of the variants described in Fig. 4 reflect 
defective birth and survival of R8s, which consequently impairs secondary photoreceptor 
recruitment. 
An Asp residue at the MAPK site elicits inappropriate earlier activity of M8 
We next tested if an Asp at the MAPK site renders M8 prematurely active, i.e., at 
stage-1 of the MF.  This test was conducted because M8* (lacking the ‘cis’-inhibitory CtD) 
elicits a strong loss of the eye at stage-1, whereas the CK2 mimic M8-S159D is without 
effect (Fig. 1B, D).  As (endogenous) MAPK is normally activated at stage-2/3 of the MF 
where R8s are selected by lateral inhibition, we reasoned that an Asp at the MAPK site 
might well bypass the need for EGFR/MAPK signaling, and exhibit premature activity at 
stage-1, in a manner akin to M8*. 
Indeed, the MAPK-mimic (M8-S151D) and the dual-kinase mimic (M8-
S151D+S159D) both elicit a reduced eye upon expression at stage-1 (with hH10Gal4) with 
similar potency (Fig 6A, B), and perturb the ommatidial lattice and the position of the IOBs 
(Fig. 6A’, B’).  No reduced eye was observed with M8-S151A+S159D (mimics CK2, but not 
MAPK), and neither did this variant elicit defects in the ommatidial lattice or the position of 
the IOBs (Fig. 6C, C’).  These data seem consistent with the possibility that both CK2 and 
MAPK are needed for proper activation of M8 in a timely manner at stage-2/3; this 
regulatory system is bypassed by Asp mutations or by deletion of the CtD. 
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Altered EGFR signaling modulates M8 variants with an intact MAPK site 
Given the importance of the MAPK site for M8 activation, we directly tested for a role 
for EGFR signaling.  We used egfrf24, a loss of function allele, which does not perturb the 
eye/R8s in the heterozygous state (data not shown) but is lethal when homozygous.  We 
reasoned that if EGFR/MAPK signaling activates M8, then halved EGFR levels should 
attenuate the amount of active MAPK, and result in diminished phosphorylation of M8.  If so, 
M8-S159D (mimics CK2 but an intact MAPK site) should become hypo-phosphorylated in 
egfrf24/+ flies, thereby dampening the severity of its reduced eye.  In contrast, the MAPK-
mimic (M8-S151D) and the dual-kinase mimic  (M8-S151D+S159D) should be refractory to 
halved EGFR signaling by virtue of the Asp residue at the MAPK site.   
Both of the suggested predictions bear out.  The CK2 mimic M8-S159D was 
expressed with scaGal4, given the significant effect on the eye with this stage-2/3 driver.  
Compared to its effects in an egfr+ background (Fig. 7A), the severity of the reduced eye of 
M8-S159D is significantly attenuated in egfrf24/+ flies (Fig. 7B), a result supported by 
quantitative analysis of eye size (Fig. 7C).  Staining of eye discs reveals the cell specificity 
underlying the restoration of eye size in the egfrf24/+ background.  Expression of the CK2 
mimic M8-S159D in egfr+ flies (Fig. 7A’) elicits strong loss of patterned R8s (Sens+ cells), 
impairs R8 survival (maintenance of Sens levels) and results in diminished recruitment of 
secondary photoreceptors (ELAV+ cells).  These R8 defects are strongly suppressed in an 
egfrf24/+ background (Fig. 7B’ and B”). 
A similar analysis was conducted with the MAPK-mimic (M8-S151D) and the dual 
kinase mimic (M8-S151D+S159D), but utilized the driver 109-68Gal4 due to lethality upon 
expression with scaGal4 (see Fig. 3D).  With both of these variants the severity of the 
reduced eye was indistinguishable in egfr+ versus egfrf24/+ backgrounds, qualitatively 
(compare Fig. 7D, E to Fig. 4B, C) as well as quantitatively (Fig. 7F, graph includes values 
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from Fig. 3E).  Staining of eye discs revealed that these two variants elicit R8 defects 
indistinguishable from those described earlier in egfr+ flies (Fig. 5, and data not shown).  
Thus eye/R8 defects of M8 variants with a phosphomimetic Asp at the MAPK site are 
insensitive to halved EGFR/MAPK signaling. 
Deletion of the CK2 or MAPK site mimics Asp-variants of M8 at these two kinase sites 
 We next sought to test the contributions of the CK2 and MAPK sites to ‘cis-inhibition’.  
We were intrigued by the findings that the MAPK-mimic M8-S151D or dual-kinase mimic 
M8-S151D+S159D both elicited a reduced eye and R8 defects at stage-1 of the MF (Fig. 6) 
in a manner akin to non-inhibited and constitutively active M8* (see Fig. 1B).  These studies 
did not, however, resolve if the MAPK site in conjunction with CK2 imposes cis-inhibition on 
M8, or if the similar stage specificity of the MAPK-mimic and M8* is purely incidental.  
Specifically, we sought to determine if modification by CK2+MAPK serves primarily as a 
conformational switch, rather than for binding of repressive cofactors (other than Gro) to the 
phosphorylated CtD of M8.  For this, we asked if deletion of the CK2 or MAPK site renders 
M8 active, thereby mimicking the outcomes of Asp mutations at these kinase sites.  We 
deleted just the consensus sites for these two kinases.  The first, M8-ΔCK2 lacks the CK2 
site S159DCD, whereas the second M8-ΔMAPK lacks the MAPK site PLS151P (Fig. 8A).   
Based on the ‘cis’-inhibition model and studies with Asp mutations at the CK2 and/or 
MAPK sites (Figs. 1, 3-7), we made three predictions.  First, M8-ΔCK2 should resemble the 
CK2-mimic M8-S159D and elicit a reduced eye at stage-2/3, but not stage-1.  Second, M8-
ΔMAPK should mimic M8-S151D and elicit a reduced eye at stage-1 and stage-2/3.  Third, 
the reduced eye of M8-ΔCK2 should be mitigated by halved egfr dosage, whereas that of 
M8-ΔMAPK should be insensitive. 
Indeed, all three predictions bear out (Fig. 8).  At stage-1, M8-ΔCK2 is largely 
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inactive, whereas M8-ΔMAPK elicits a ~50% reduction of the eye (Fig. 8B, C, D).  In 
contrast, M8-ΔCK2 elicits a strong loss of the eye at stage-2/3 (Fig. 8E), whose severity is 
significantly attenuated in an egfrf24/+ background (Fig. 8F).  This result is supported by 
quantitative analysis of eye size (Fig. 8G).  As predicted, expression of M8-ΔMAPK at stage-
2/3 elicits a reduced eye of comparable size in egfr+ or egfrf24/+ backgrounds (Fig. 8H, I), 
results also supported by quantitative analysis of eye size (Fig. 8J).  Thus deletion of the 
CK2 and MAPK sites elicits M8 activity and eye defects that closely mimic the effects of Asp 
mutations at these respective kinase sites.  We conclude that the two flanking kinase sites 
participate in ‘cis’-inhibition of M8, and that this control is bypassed by deleting kinase 
consensus sites within the P-domain (Fig. 8), the introduction of phospho-mimetic Asp 
residues or by the complete loss of the CtD, as with M8* (Fig. 1B). 
PP2A may target the MAPK site during M8 regulation 
Recent studies from our lab reveal a role for the phosphatase PP2A in birth of 
patterned R8s (Bose et al., 2014).  Relevant to the studies described here, overexpression 
of widerborst (wdb), a PP2A regulatory subunit, rescues the eye /R8 defects of the CK2 
mimic M8-S159D (Fig. 9A).  No rescue was evidenced upon co-expression of UAS-LacZ, 
excluding the possibility that rescue reflects competition between two UAS-constructs for a 
limiting amount of Gal4 protein.  The modulation of the eye defects of M8-S159D by wdb 
raised the prospect that PP2A targets the MAPK site, rather than that for CK2.   
We thus tested if PP2A opposes the effects of EGFR/MAPK signaling, by asking 
whether co-expression of UAS-Wdb modulates the reduced eye of the MAPK-mimic (M8-
S151D) and the dual-kinase mimic (M8-S151D+S159D).  The reduced eye of either variant 
upon co-expression of UAS-Wdb (Fig. 9B, C) appeared similar to that in its absence (Fig. 
compare with Fig. 4B, C), a result supported by quantitative analysis of eye size (Fig. 9D).  
The eye sizes in the presence of ectopic Wdb were statistically similar to those in its 
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absence (note that Fig. 9D includes data values from Fig. 4).  Hence, unlike the CK2-mimic 
M8-S159D, an Asp residue at the MAPK site renders M8 insensitive to Wdb, suggesting that 
this phosphatase might oppose M8 activation by EGFR/MAPK signaling.  In summary, we 
conclude that the highly conserved MAPK site is important for activation of M8 in a spatially 
precise manner in the MF, and that this activation is antagonized by PP2A. 
Discussion 
 The studies described here reveal that the highly conserved MAPK site in M8 is 
important for repressor activity in the developing eye, but appears to be dispensable during 
bristle development.  Specifically, our studies have utilized Ala/Asp variants of the MAPK 
site in wild type (Figs. 1, 3, 4, 5, 6) and egfr mutant backgrounds (Fig. 7).  These findings 
support an important role for EGFR/MAPK signaling in controlling M8 repression of Ato.  In 
addition, our studies on deletion variants of M8 (Fig. 8) reveal that both kinase consensus 
sites contribute to ‘cis’-inhibition, which is regulated by multi-site phosphorylation.  Finally, 
our analysis of PP2A-Wdb (Fig. 9) raises the prospect that this phosphatase targets the 
MAPK site of M8.  The conservation of sites for these two kinases in M7, M5 and Mγ raises 
the prospect that this regulatory mechanism has a broader impact that has been realized.  
Together, our studies reveal that instead of acting merely in a dosage-dependent manner, 
distinct tissue-specific regulatory mechanisms control repression by E(spl) proteins.   
Multi-site phosphorylation exerts spatial control over M8 activation in the eye 
The studies we describe here expand on our understanding of the role of the 
conserved P-domain in M8.  Our data suggest a revised model wherein conversion of the 
‘cis’-inhibited state of M8 to an active repressor of Ato depends upon phosphorylation of the 
CK2 and MAPK sites, and that the precise (restricted) activation of this key Ato repressor at 
stage-2/3 of the MF occurs in response to EGFR signaling (Fig. 10).  If so, it would suggest 
that EGFR signaling, which is required to activate MAPK at stage-2/3, is crucial for inhibitory 
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effects of Notch to occur properly, and without which R8 patterning and eye development 
would be perturbed.  The emerging role for PP2A in regulation of M8 activity raises the 
prospect that this phosphatase may play two potential roles, not necessarily mutually 
exclusive.  By antagonizing modification at the MAPK site, PP2A may control the amount of 
active (non ‘cis’-inhibited) M8, or it may act to control M8 inactivation immediately upon the 
selection of single R8s.  The former regulation may thus impose control over ‘signal 
amplitude’ (amount of active M8), whereas the latter would control ‘signal duration'.  Our 
studies, which do not discriminate between these possibilities, nevertheless reveal that 
repression by E(spl)-M8 is controlled by PTM. 
We note that our analyses do not reveal the epistatic relationship between CK2 and 
MAPK, because demonstration of the order of M8 phosphorylation necessitates isoform- 
and phospho-specific antibodies.  Our efforts to raise antibodies that recognize specific 
phosphorylated forms of M8s CtD have not been successful, as they display cross-reactivity 
not only with unmodified M8 but with other members that share sequence similarity in their 
CtDs (M5, M7, Mγ).  In light of the close conservation of the CK2 and MAPK sites in the 
E(spl) proteins M7, M5 and Mγ, the likelihood is high that this manner of regulation may 
have a broader impact in tissues where these bHLH proteins function.  We discuss the 
implications of our findings in the context of two signaling pathways, Notch and EGFR, 
which are vital not only to R8 ontogeny, but also to subsequent stages of retinal 
histogenesis. 
Notch and the specification of the R8 cells 
 The key role of Notch as the driver for lateral inhibition is indisputable.  Detailed and 
elegant studies have shown that loss of Su(H) or the E(spl)C leads to the specification of 
excess (‘twinned’) R8s, a hallmark of impaired lateral inhibition.  The developmental 
outcome of loss of Notch is more complicated, in particular at the onset of retinal 
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histogenesis because this receptor plays dual roles during birth of the R8 cells.  Notch is first 
needed for ‘proneural enhancement’, a positive feedback loop that is necessary to 
upregulate Ato levels in an Ato+Da-dependent manner, after which it is needed for lateral 
inhibition.  The mechanism underlying these two antagonistic functions has, to our 
knowledge, remained undefined at the molecular level.  Our studies suggest that spatially 
controlled phosphorylation of M8 may introduce a ‘time-delay-circuit’.  Without this delay Ato 
upregulation would be impaired, and Ato levels in the pre-R8 clusters would not achieve the 
threshold necessary to adopt the R8 fate.  The strong loss of Ato upregulation that is seen 
with E(spl)D or upon stage-1 expression of M8* would be consistent with our model, and 
underscore the prescient suggestion of Giebel and Campos-Ortega that this region (the 
CtD) may impose control over repression.   
EGFR and the specification of the R8 cells 
While there are numerous lines of evidence for the contribution of MAPK in retinal 
determination, the role for the EGFR pathway in R8 selection is still unclear.  The 
EGFR/MAPK signaling pathway has been suspected to play a role in R8 patterning.  For 
example, egfr-/- clones display the specification of ‘twinned’ R8s, a phenotype also manifest 
in clones of the downstream effectors Ras and Raf (Yang and Baker, 2001).  A similar 
analysis of MAPK-/- clones has been stymied due to cell lethality.  Nevertheless, we note 
with interest that a ‘twinned’ R8 phenotype is not seen in clones of pointed (pnt), the nuclear 
effector of EGFR signaling, or anterior open (aop or yan), that acts as a repressor (Yang 
and Baker, 2003).  Moreover, active dual-phosphorylated MAPK (dp-ERK) is detectable in 
cells at stage-2/3 of the MF (Kumar et al., 1998), and this staining is lost in egfr-/- clones 
(Lesokhin et al., 1999), suggesting that MAPK activation at this stage of the MF is not being 
driven by another RTK.  Surprisingly, and unlike the canonical mode of EGFR/MAPK 
signaling, dp-ERK does not translocate to the nucleus and instead appears cytoplasmic, 
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referred to as the ‘cytoplasmic-hold’ (Kumar et al., 2003).  This is intriguing, because in this 
location active-MAPK would not be able to phosphorylate either Pnt or Yan, which are 
constitutively nuclear proteins (Shilo, 2003).  The identity of the proteins targeted by this 
active cytosolic MAPK has remained unknown.  Do these studies suggest that active MAPK 
may act to regulate M8 in the cytosol and that this activated protein then enters the nucleus 
to mediate repression?  While the answers to this question are presently unknown, we note 
that the default location of the M8 homolog HES6 is cytosolic in the myogenic program (Gao 
et al., 2001), and nuclear localization of this repressor is closely coupled to induction of 
differentiation, suggesting that the nucleus is not the default location of (at least) this HES 
repressor.   
 Then how does MAPK phosphorylation precisely affect M8 activity?  We have 
previously proposed that M8 is an autoinhibited protein, an intramolecular restraint upon 
repressor capabilities that keeps the protein in an inactive state (Kahali et al., 2010b; 
Karandikar et al., 2004).  Surprisingly, the deletion of the CK2 site, which in a sense mimics 
the phosphorylation, leads one to propose therefore the simplest interpretation that it is the 
CK2 site that itself imposes some protein-protein contact that is responsible for controlling 
the onset of repression.  However, this variant at an earlier stage of the furrow fails to 
perturb the eye field, which now necessitates a simultaneous deletion of the MAPK site 
indicating that neither the CK2 nor the MAPK phosphorylation is likely to act as a scaffold or 
serve as a basis for secondary modulation.  In fact, these phosphorylations may be required 
purely at a level of intramolecular protein contact.  If so, it is reasonable to suggest that both 
CK2 and MAPK act to restrain autorepression, and the data presented with Asp 
replacement at both kinase sites as well as the deletion of either kinase site, would suggest 
that the protein is under dual control.  We think that dual control is a mechanism to allow for 
the precise regulation of the protein.  One question that has always remained unanswered is 
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what triggers the modification of M8 by CK2?  This kinase does not respond to extracellular 
or intracellular signaling pathways, but clearly does not appear to modify M8 on its own 
because co-expression of CK2 and M8 does not pheno-copy the effects of the Asp.  Our 
studies do not allow us to tell whether CK2 modification acts prior to that of MAPK.  In any 
event however, given that MAPK activation is exclusively dependent on EGFR pathway 
activation, it therefore is reasonable to suggest that the gate-keeping function could well be 
mediated by EGFR.  
 These studies for the first time demonstrate a developmental context under which 
the MAPK site in M8 protein is of biological consequence.  As shown in the last figure (Fig 
10), co-ordinated functions of several kinases (CK2 and MAPK) and phosphatase (PP2A) 
control the regulatory output of M8 repression.  These PTMs may be a way to balance the 
amplitude of the M8 signal or the duration.  While phosphorylation by CK2 and MAPK allows 
for precise on-set of repressor activity of M8 and thus for R8 selection, de-phosphorylation 




Materials and Methods 
Construction of M8 variants:  M8 variants with Ala/Asp substitutions at the known 
phosphorylation site for CK2 (Ser159) and/or that predicted for MAPK (Ser151) were 
generated by PCR based site-directed mutagenesis.  M8 variants harboring deletions of the 
CK2 (S159DCD) or MAPK (P149LSP) consensus motifs were generated by inverse-PCR.  
In both cases (Ala/Asp or deletion variants), the forward and the reverse primers 
incorporated EcoRI and BamHI sites 5’ and 3’ to the coding region, respectively.  The 
forward primer incorporated a KOZAK consensus (CAAC) immediately 5’ to the ATG codon 
for efficient expression.  All constructs were fully sequenced to confirm the presence of only 
the intended mutations.  
Germ line transformation: The Ala/Asp variants of M8 targeting the CK2 and/or 
MAPK sites were cloned into the vector pUAST-attB, whereas the deletion variants were 
cloned into pUAST (Brand and Perrimon, 1993).  Transgenic lines were generated using a 
commercial embryo injection facility (BestGene, Inc.).  All pUAST-attB constructs were 
integrated using the ϕC31-docking site at 68E on the third chromosome (Bateman et al., 
2006).  The transgenic lines were verified by PCR amplification and sequencing of the 
PUAST-attB construct, and a single molecularly defined line was used in the studies.  For 
the pUAST-constructs, w+ progeny were identified and the insertion site was mapped by 
standard approaches using chromosomes harboring dominant markers.  In the case of 
pUAST constructs, 10 independent insertions of M8-ΔCK2 and M8-ΔMAPK were generated, 
and of these ≥5 have been used in the studies. 
Biochemical analysis:  Protein-protein interactions were analyzed by the LexA-
based version of the yeast interaction trap.  The bait and prey constructs were expressed as 
C-terminal fusions with DNA-binding domain of LexA and the activation domain (AD) of B42, 
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respectively.  The yeast strain EGY048p was used to evaluate protein interactions, as 
described (Trott et al., 2001).  
Fly stocks: The Gal4 drivers were obtained from Bloomington Stock Center 
(denoted by the prefix B).  These drivers are 109.68Gal4 (B6479), hH10 Gal4 (Fischer-Vize et 
al., 1992) scaGal4 (Giebel and Campos-Ortega, 1997).  The DER mutant line egfrf24 (B6500) 
was also obtained from Bloomington Stock Center.  wdbEP3559 flies were a gift from Amita 
Sehgal (U. Penn).  
Eye and bristle phenotypes:  All crosses were performed on standard Yeast-
Glucose medium at 24°C, unless indicated otherwise.  Fly heads were dehydrated by 
sequential passage through a graded alcohol series for 24 hours each (25%-50%-75%-
100%), and finally passed through Hexamethyldisalinaze.  Heads were mounted on EM 
stubs, dried for 24 hours, sputter coated with gold and examined with a JEOL-6400 
scanning electron microscope at an accelerating voltage of 10-20kV.  Images were 
processed with Adobe Photoshop and collated in Adobe Illustrator.  The reduced eye was 
quantified from ~20 adult flies that were photographed using a Leica MZ16 
stereomicroscope equipped with a Leica DFC-480 digital camera.  Facet numbers were 
counted from TIFF images.  A similar approach was used to determine bristle phenotypes.  
Eye size (facet counts) and bristle defects were statistically analyzed using Student’s T-test. 
Immunostaining and confocal microscopy:  Eye imaginal discs were isolated 
from late third instar larvae and processed as described (Kavler et al., 1999) with minor 
modifications.  After isolation, discs were fixed in 4% paraformaldehyde in 1x phosphate 
buffered saline (PBS) for 45 minutes at 4°C.  After fixation, discs were washed three times 
with PBS containing 0.3% Triton X-100 (PBS-TX) for 15 minutes each.  The discs were 
incubated for 12-14 hours at 4°C in PBS-TX containing primary antibody.  The following 
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antibodies were used; guinea pig anti-Sens (gift from Hugo Bellen, HHMI-Baylor) at a 
dilution of 1:2000 and mouse anti-ELAV (DSHB, Iowa) at a dilution of 1:1000.  Following 
primary antibody binding, eye discs were washed three times with PBS containing 0.3% 
Triton X-100 and then incubated with secondary antibody at room temperature for 2-3 hours.  
The secondary antibodies (Molecular Probes) used for are, goat anti-guinea pig-IgG coupled 
to Alexa Fluor 633 (1:1000) and goat anti-mouse-IgG coupled to Alexa Fluor 488 (1:1000).  
The discs were mounted in 60% glycerol, and viewed on an Olympus FluoView (FV100) for 
confocal imaging.  Images were acquired every 1um along the apicobasal axis of the discs 
and then compressed as a Z-stack without the removal of any layers.  Compressed Z-stacks 
were exported as TIFF files and collated in Adobe Illustrator. 













Fig. 10: MF specificity of M8-S159D.   
(A) Schematic representation of the morphogenetic furrow (MF) depicting the expression 
domains of different Gal4 drivers.  The cell fates at different stages, spanning the MF are 
represented in colored shades.  (B) The eye phenotype of CK2 variants (random insertion 
lines) driven by two different drivers, scaGal4 and 109-68Gal4 at stage-2/3 of the MF.  (C,D) 
Scanning EM of adult eye at a magnification of 200x.   (C) Overexpression of CK2 
phosphomimectic form M8-S159D, at stage-2/3 of the MF perturbs the eye.  (D) M8-S159D 
fails to generate any eye defect at stage-1 of the MF.  (E) Ommatidial (facet) counts were 






Fig. 11: Conservation of Ser residues in the P-domain of E(spl)-M8.   
(A) The functional domains of E(spl)-M8 are represented by a basic domain (DNA binding), 
an HLH domain (dimerization), a second HLH region, the Orange domain (interaction with 
Ato/ASC) and a C-terminal WRPW motif (Gro-binding).  While these domains are highly 
conserved among all the E(spl) members, the length/sequence heterogeneity is largely 
confined to the C-terminal domain (CtD), the region between Orange and WRPW.  The CtD 
has a phosphorylation domain (P-domain) with several conserved Ser residues.  The 
mammalian Hes6 has additional Asp residues in the CtD (black arrow) (B) Sequence 
alignment of P-domain of E(spl)-M8 homologs in 12 Drosophila species, Stalk-eyed fly 
(T.dalmani) and the mammalian homolog of E(spl)-M8 in mouse Hes6 and human Hes6.  
The blue and yellow shaded boxes meet the consensus for MAPK and CK2 phosphorylation 
motifs respectively.  Conserved phosphorylatable Ser residues are represented in bold red.  
Phylogenetic relationship of E(spl)-M8 of all the 12 Drosophila species are represented at 
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the right side of Panel B.  (C) The Φc31 M8 phospho variants used for the study.  M8-
S159D represents the CK2 mimic and M8-S151D represents the MAPK mimic.  M8-
S151D+S159D mimics CK2+MAPK dual phosphorylated form.  M8-S151A+S159D is the 
CK2 phosphomimetic and MAPK refractory form of the protein.  Two-hybrid interaction of the 
M8 variants with Gro (co-repressor) were measured as Lac Z activity (Miller Units) and 







Fig. 12: MAPK refractory but CK2 mimic does not perturb the eye. 
(A) M8-S151A+S159D (CK2+no MAPK) fails to generate any eye defect at stage-2 of the 
MF.  (B, C) Loss of MC’s on the heminotum displayed by M8-S151A+S159D and CK2 mimic 
M8-S159D.  (D) MAPK mimic (M8-S151D) and dual-kinase mimic (M8-S151D+S159D) elicit 







Fig. 13: Secondary phosphorylation enhances M8 activity.   
(A-D) Adult eye phenotype of all the phospho-mimetic variants driven by 109-68Gal4 at 
stage-2/3 of the MF.  (E) Ommatidial (facet) counts were determined in ≥20 of the indicated 
genotypes.  Asterisk denote P-value <0.001.  (A’-D’) The phosphor-variants elicited MC loss.  
(F) Heminotum MC loss was determined in all the four variants.  Asterisks denote P-value 




Fig. 14: Phosphomimics perturb R8 birth and differentiation. 
Eye disc of the aforementioned genotypes were immunostained with α-Sens (magenta) and 
α- ELAV (green) to determine R8 differentiantion and secondary photoreceptor recruitment 
respectively.  Arrow indicates direction of MF progression.  (A) CK2-mimic M8-S159 shows 
absence of closely juxtaposed ELAV+ cluster.  Note that MAPK mimic M8-S151D (C) and 
CK2+MAPK dual mimic M8-S151D+S159D (D) random patches of non-specified and non-
differentiated retinal tissue.  On the contrary, M8-S151A+S159D (B) shows uniformity in 






Fig. 15: MAPK mutation causes precocious M8 repressor activity at stage-1 of MF.   
75 
 
(A-C) Adult eye phenotypes of different M8 variants at stage-1 of the MF.   Both M8-S151D 
(A) and M8-S151D+S159D (B) perturb the eye field whereas M8-S151A+S159D (C) fails to 
generate any eye defect at stage-1 of the MF.  (A’-C’) 1000x magnification of the 
corresponding genotypes in panels (A-C).  There are extra IOBs specified for MAPK mimic 
(A’) as well as the MAPK+CK2 mimic (B’).  The CK2+no MAPK mimic (C’) fails to specify 
extra IOBs. Ommatidial (facet) counts were determined in ≥20 adult flies.  Asterisk denote P-





Fig. 16: Decreased EGFR levels rescue reduced eye of CK2 mimic only.   
(A-B) Scanning EM of adult eye at a magnification of 200x.  (A) Overexpression of CK2 
phosphomimectic M8-S159D form at stage-2/3 of the MF at an egfr+/+ background perturbs 
the eye.  (B) M8-S159D when expressed at egfrf24/+ background restores the eye field.  
Graph shows ommatidial count of the adult eyes. Data labeled A and B correspond to the 
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adult eyes shown in panel (A) and (B).  Facet count was determined in ≥20 flies.  Asterisk 
denotes P-values< 0.001.  (A’-B’) Eye discs of genotypes indicated in A and B were 
immunostained with α -Sens (magenta) and α - ELAV (green) to assess R8 differentiation 
and secondary photoreceptor recruitment.  Panel (B”) shows a magnified image of panel 
(yellow box in B’) to highlight the rescue of differentiated R8s and Elav clusters.  (D,E) 
Overexpression of MAPK phosphomimectic M8-S151D and CK2+MAPK dual mimic M8-
S151+159D at stage-2/3 of the MF at egfrf24/+ background fails to restore the eye field.  
Facet count was determined in ≥20 flies.   Data labeled D and E correspond to the adult 





Fig. 17: Deletion variants of M8 perturb eye development. 
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(A) Schematic representation of the P-domain deletion variants of M8.  M8-ΔCK2 lacks the 
CK2 motif and M8-ΔMAPK lacks the MAPK motif.  The deletion variants were expressed at 
stage-1 of the MF driven by hH10Gal4.  (B-C) M8-ΔCK2 fails to generate any overt eye defect 
(B) whereas M8-ΔMAPK generates a reduced and rough eye phenotype (C).  (D-E) At an 
egfr+/+ background, M8-ΔCK2 overexpression driven by scaGal4 leads to a rough and 
reduced eye (D).  The eye defect of M8-ΔCK2 is rescued at a halved dosage of egfrf24/+ 
background (E).  Similar studies involving M8-ΔMAPK was precluded as scaGal4 driving the 
deletion variant led to embryonic lethality (see inset Fig 8).  (F-G) In order to circumvent the 
problem, weaker driver 109-68Gal4 was used which resulted in a rough and reduced eye 
phenotype (F) at an egfr+/+ background.  The eye defect of M8-ΔMAPK at stage-2/3 was 
not rescued in a halved dosage of egfrf24/+ background (G).  The graphs at the bottom 
panel are for the corresponding genotypes.  Ommatidial (facet) count was determined in ≥20 





Fig. 18: MAPK site in M8 may be a target for modulation by PP2A. 
(A) Overexpression of widerborst (wdb) rescues the eye defects of CK2 mimic M8-S159D 
(adapted from (Bose et al., 2014)).  Scanning EM of the adult eye at 200x magnification (B-
C).  Co-expression of Wdb fails to rescue the reduced eye phenotype due to overexpression 
of  (B) M8-S151D and (C) M8-S151D+S159D.  Graph shows ommatidial (facet) counts of 
the adult eyes.  Data labeled B and C correspond to the adult eye shown in panels B and C.  
The +/+ controls for each corresponding genotype are adapted from Fig 3.  Facet counts 





Fig. 19: Phosphorylation and dephosphorylation regulates M8 repressor activity 
during retinal neurogenesis.   
Model for M8 regulation.  In the auto-inhibited state, the CtD loops back and blocks the HLH 
and/ Orange domain thereby prohibiting M8 interaction with Ato.  CK2 and MAPK 
phosphorylation converts M8 into an active repressor for Ato, whereas PP2A mediates 
inactivation, either by a conformational change or by marking the protein for modifications by 
unknown targets for proteasomal degradation.  The cartoon in the right represents the 
spatio- temporal regulation of M8 by phosphorylation and dephosphoryation by all these 
different factors in a 48-hr window of MF progression.  As all the photoreceptors at stage-1 
slowly starts accumulating Ato, M8 is produced at stage-2/3; undergoes post-translational 
modification (PTM) by CK2 and MAPK and restricts Ato in R8 photoreceptors.  Immediately 
after, PP2A restricts M8 activity either by modulating the duration or amplitude of the 











During autoinhibition, the C-terminal domain (CtD) of M8 mediates a ‘cis’ interaction 
with the residues of the bHLH through the Orange domain.  At the time of R8 specification, 
M8 undergoes phosphorylation by CK2 at the CtD, which is a necessary step for repressing 
the proneural protein Atonal.  The CK2 site resides in a region that conserves additional Ser 
residues.  This region of conserved Ser residues has putative sites for modifications by 
other kinases and has been termed as the P-domain (phosphorylation domain).  Using 
deletion variants of specific kinase motifs and the entire P-domain, we demonstrate that this 
Ser-rich region is necessary for autoinhibiting M8.  We have also tested this model for 
inhibition by co-expressing the CtD-peptide, which rescues the eye and the bristle defects of 
the deletion variants.  This key regulation by the P-domain is bypassed by the E(spl)D 
mutation encoding the truncated protein M8*, which inhibits Ato precociously. Additionally, 
we provide evidence that the P-domain may undergo modulation by Slmb, a subunit of E3 
ligase, which regulates proteasomal degradation.  Together these studies provide evidence 
that the P-domain of CtD has a role in autoinhibition of M8 and also assists in protein 





The Notch signaling pathway is highly conserved in invertebrates and vertebrates, 
and is involved in induction as well as restriction of cell fates.  The functions of Notch have 
been exceptionally well analyzed during neurogenesis, where it mediates lateral inhibition to 
regulate dichotomy between neural versus epidermal cell fate (Artavanis-Tsakonas et al., 
1999; Baonza and Freeman, 2001; Bray, 2006).  The two sensory organs of Drosophila, 
which have been studied extensively to understand the mechanism of lateral inhibition 
include the compound eye and the mechanosensory bristles, such as the macrochaetes 
(MC’s), microchaetes (mc’s) and the interommatidial bristles (IOB’s) (Modolell, 1997; 
Modolell and Campuzano, 1998; Simpson, 1990).  Although different in structure, eye and 
bristle development involves similar genes and cell fate/lineage decisions.  Studies involving 
these two model structures have led to our present day understanding of the core 
components of the Notch pathway and how it regulates cell fate specification. 
At the onset of neurogenesis, proneural basic-helix-loop-helix (bHLH) activators 
encoded by atonal (ato) or the achaete-scute complex (ASC) is expressed in groups of cells, 
called proneural clusters (PNCs) (Heitzler et al., 1996; Jarman et al., 1995; Jarman et al., 
1994; Kiefer, 2005; Skeath and Carroll, 1991).  While ato is required for eye development, 
ASC expression is critical for bristle morphogenesis (Calleja et al., 2002; Campos-Ortega, 
1998; Jarman et al., 1995; Jarman et al., 1994).  The activities of these proneural proteins 
drive the formation of the PNCs, in which all cells have somewhat equal potential to adopt 
the neural fate (Dambly-Chaudiere and Vervoort, 1998; Frankfort and Mardon, 2002; Gibert 
and Simpson, 2003; Hsiung and Moses, 2002).  From each PNC, however, only a single cell 
becomes the neural progenitor, the ‘founding’ R8 photoreceptor in case of the eye or the 
bristle sensory organ precursor (SOP), while the others are redirected to an alternative fate.  
This restriction of the R8/SOP from a PNC is termed lateral inhibition (Axelrod, 2010; Castro 
et al., 2005; Simpson, 1990).  During this process, the presumptive R8/SOP activates Notch 
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in the adjacent cells of the PNCs (the non-SOPs/R8s).  Specifically, activation of Notch 
results in the cleavage and nuclear translocation of it’s intracellular domain (Nicd), where it 
associates with and activates Suppressor of Hairless (Su(H)) leading to the transcription of a 
family of basic Helix-loop-Helix (bHLH) repressors, collectively called the Enhancer of split 
Complex (E(spl)C) ((Bailey and Posakony, 1995; Lecourtois and Schweisguth, 1995) (Bray, 
1997; Delidakis and Artavanis-Tsakonas, 1991).  The E(spl) repressors complex with the co-
repressor Groucho and antagonize Ato/ASC to restrict the R8/SOP fate in all but one cell of 
a PNC. 
Despite our understanding of the Notch pathway components and the mechanism of 
activation of E(spl) genes, our knowledge on the roles of functional domains of these 
repressors and their mode of regulation still remains unclear.  Given their conserved 
structure, a long-standing view is that these proteins are functionaly redundant, and that 
repression by these proteins is purely a reflection of their dosage.  A body of genetic 
evidence contradicts this view.  For example, while loss of E(spl)C elicits ectopic R8s/SOPs, 
overexpression of the various E(spl) members only affected bristle-SOP fate but R8 
specification remained largely unperturbed (Giebel and Campos-Ortega, 1997; Ligoxygakis 
et al., 1998; Nakao and Campos-Ortega, 1996).  Of the three E(spl) members, M8, Mδ and 
Mγ which are expressed in the morphogenetic furrow (MF) during eye development, only Mδ 
overexpression elicit loss of R8’s (Ligoxygakis et al., 1999; Nagel et al., 1999).  The first line 
of evidence that protein dosage of bHLH repressors is insufficient for inhibition of R8 cell 
came in light when E(spl)D, a unique dominant allele of m8 elicited dominant loss of R8s 
and the eye (Kahali et al., 2009a; Nagel and Preiss, 1999).   
The dominant eye defect elicited by E(spl)D allele can be attributed to its enhanced 
interaction with and antagonism of Ato (Nagel and Preiss, 1999).  It was paradoxical that a 
similar result could not be recapitulated by overexpression of full length M8.  Detailed study 
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revealed that the protein encoded by the E(spl)D allele is a truncated protein called M8*, 
which lacks 56 C-terminal residues (Nagel et al., 1999; Tietze et al., 1992).  It was this 
discovery that led to presciently suggest that the C-terminal domain (CtD) of M8 might have 
regulatory influence on its repressor activity (Campos-Ortega, 1997).  Later studies show 
that the CtD of M8 is phosphorylated by CK2 at a specific motif, a region missing in M8* 
(Trott et al., 2001).  As a consequence of this post-translational modification (PTM), M8 
undergoes a conformational change, which enables it to bind and antagonize Ato.  
Replacement of the CK2 phospho-acceptor (Ser159) with a phosphomimetic Asp residue 
(M8-S159D aka M8-SD) elicits exacerbated loss of R8s and the eye with a potency akin to 
E(spl)D.  Moreover, M8-SD interacts with Ato with a binding strength equal to that of M8*.  
Consequently it was proposed that the CtD autoinhibits full length M8.  Phosphorylation 
displaces this intra-molecular interaction permitting repression of Ato.  This appears to be 
the case because co-expression of non-phosphorylated M8-CtD rescues the reduced eye of 
CK2-mimic M8-SD, even though the interaction would be in ‘trans’.  A CtD with Asp at the 
CK2 site failed to rescue the R8s and eye defect (Kahali et al., 2009b).These results 
implicate CK2 as a regulator of R8 selection through the activation of M8 (Karandikar et al., 
2004). Accordingly, loss of CK2 in otherwise wild type flies compromises lateral inhibition 
and elicits the specification of excess R8s from the IGs (Bose et al., 2006). 
In case of M8, M5, M7, Mγ and the human homolog of E(spl) protein, HES6, the CK2 
site is located in a region termed as the P-domain, which reveals the presence of additional 
conserved Ser residues.  This Ser rich region represents consensus sites for 
phosphorylation by MAPK, CK1 and GSK3.  In case of HES6, the PxSP motif in its tail 
region has already been shown to be a target for MAPK, an effector of EGFR pathway, 
although its developmental consequences are presently unknown (Belanger-Jasmin et al., 
2007).  Although, mutations in CK1 or GSK3 have no known consequences in R8 
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patterning, the role of EGFR in R8 specification has long been suspected.  The close 
clustering of CK2 and MAPK sites on the CtD raises questions on their role on regulating 
repressor activity of M8.  Furthermore, recent studies from our lab have shown that 
dephosphorylation of M8 by phosphatase PP2A may play a role in antagonizing Notch 
signaling (Bose et al., 2014).  It is speculated that PP2A may control the amount of active 
(non-inhibited) M8, or it may act to control M8 inactivation immediately upon the selection of 
single R8s, providing a rapid and potent mechanism to shut off M8.  Additionally, a large-
scale Drosophila protein-protein interaction screen has revealed supernumerary limbs 
(Slmbs) to be an interacting partner of M8 (Guruharsha et al., 2012).  Slmb is the substrate 
specificity subunit of the SCF E3-ubiquitin ligase that targets proteins for degradation via the 
26S proteaosome.  Modifications of Ser 154, 155 and159 (CK1, GSK3 and CK2 sites 
respectively) in the CtD of M8 via phosphorylation may generate a Slmb-binding consensus 
motif, thereby eliciting formation of the ‘Slmb-phosphodegron’ which can be then targeted 
for degradation.  These coordinated phosphorylation-dephosphorylation and the binding of 
Slmb for proteasomal degradation may be a method for regulating M8 activity during R8 
specification. 
In this chapter we have employed deletion variants of M8 protein to explain the 
autoinhibition model.  We have used deletion variants of CK2-motif, MAPK-motif and P-
domain motif to explain the role of multisite phosphorylation as a mechanism for controlling 
regulatory activity or degradation of M8.  We have determined that the P-domain plays a 
role in the regulating the activity of M8 during R8 specification.  Our studies on the rescue of 
the eye and bristle defects of ectopic deletion variants with overexpression of the CtD-
peptide are consistent with autoinhibition.  Moreover, our studies also suggest that an intact 
P-domain is necessary for the formation of phosphodegron, which is a necessary step for 




Deletion variants and their differential roles at stage-1 of the MF 
As stated in the introduction (see above), the CtD of M8 has been suggested to play 
a role in regulation of M8 during neurogenesis.  Studies from the lab have shown that 
overexpression of the phosphorylatable CtD variant, M8-CtD, strongly represses the eye 
and bristle defects of ectopic M8-S159D at stage-2/3 of the MF.  This shows that M8-CtD 
retains the autoinhibitory activity and is able to prevent the inappropriate repression of Ato 
by CK2 mimetic form M8-S159D.  Similar autoinhibitory activity of phosphomimetic CtD 
variant M8-SD-CtD was not seen (Kahali et al., 2010b).   
To further analyze the role of P-domain in autoinhibition, we have generated deletion 
variants of M8.  We adopted random integration method to generate M8-ΔCK2, M8-ΔMAPK 
and M8-ΔPD deletion lines.  We then characterized the in vitro interaction of the variants 
with co-repressor Groucho.  In a yeast two-hybrid assay, all variants interact robustly with 
Groucho (Gro, Fig. 1B), which is essential for M8 repressor activity in vivo. 
We next assessed if overexpression of the deletion variants elicit eye defect at 
stage-1 of the MF.  The expressivity of the endogenous E(spl) genes do not correlate with 
stage-1.  Hence, it was expected that overexpression of M8 deletion variants, which have 
bypassed the need for phosphorylation and is already primed for Ato inhibition, would show 
effect at stage-1 of the MF.  On the contrary, M8-ΔCK2 overexpression at stage-1 (hH10Gal4) 
is without effect (Fig. 1C).  This stage-1 inactivity of M8-ΔCK2 was unexpected as Ato levels 
are lowest at this point of R8 birth.  In contrast, M8-ΔMAPK indeed shows a reduced eye at 
stage-1 (Fig. 1D).  This activity may reflect the necessity of phosphorylation of M8 at MAPK 
site in order to induce its repressor activity.  M8-ΔMAPK bypasses the need for 
phosphorylation at the CK2 site and is ready to repress Ato at stage-1 of the MF.  On the 
other hand, since M8-ΔCK2 still has an intact MAPK site, which cannot be phosphorylated 
at stage-1 of the MF due to lack of MAPK at that stage, fails to perturb the eye.  It was 
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expected that M8-ΔPD would perturb the eye with more severity than M8-ΔMAPK, given it is 
lacking the entire P-domain, which may be attributed to the structural component of the 
autoihibition model.  Unfortunately, any assessment with M8-ΔPD at stage-1 was not 
possible owing to embryonic lethality of this deletion variant.  Lethality was seen even in 
crosses conducted at 18C where Gal4 activity is attenuated (Fig. 1 inset) 
All three-deletion variants elicit eye defect at stage-2/3 of the MF 
We next compared the activity of the deletion variants at stage-2/3 of the MF.  To 
eliminate position effects, multiple independent lines harboring deletion constructs were 
used.  The expression of the UAS-constructs were driven with the enhancer trap scaGal4, 
that elicits Gal4 expression in stage-2/3 of the MF, where endogenous E(spl) mediates 
selection of R8 cells.  The expression of M8-ΔCK2 with scaGal4 elicits a reduced eye and 
complete loss of IOBs (Fig 2A and 2A’), a phenotype, which correlates with the expression 
of the site-specific CK2 phospho-variant, M8-S159D (see Chapter 2).  We next tested the 
effects of M8-ΔMAPK and M8-ΔPD at the same stage.  Unfortunately similar results did not 
bear out owing to embryonic lethality elicited by both the variants when expressed with 
scaGal4, even at 18C (as shown in Fig. 2 inset).  To overcome lethality we used 109-
68Gal4, a weaker stage-2/3 driver.  Expression of M8-ΔCK2 elicited a reduced eye and loss 
of the IOBs (data not shown), but not with the same severity as seen with scaGal4.  The 
difference in severity of the reduced eye may be an effect of stronger strength of scaGal4, 
as compared to 109-68Gal4.  Both M8-ΔMAPK and M8-ΔPD elicit a strong reduction in eye 
size (Fig. 2B and 2C) and also display defects in IOB patterning (Fig. 2B’ and 2C’).  No 
eye/IOB defects are seen in scaGal4/+ or 109-68Gal4/+ flies or the three M8-deletion lines 
on their own.  These studies indicate that the MAPK motif is also modulated for regulating 
M8 activity.  An intact P-domain is necessary to elicit autoinhibitory effects on the protein.  In 
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absence of the P-domain, M8 can be precociously activated which then antagonizes Ato 
and perturbs R8 specification. 
M8 deletion variants perturb R8 specification and bristle formation 
In order to determine if the deletion variants perturb birth of R8 and secondary 
photoreceptors, we next stained the third instar larval eye disc with Senseless (Sens), a 
marker for differentiated R8s and ELAV- a pan-neuronal marker.  The reduced eye upon 
expression of M8-ΔCK2 with scaGal4 (Fig. 3A) reflects strong loss of R8s (Sens+ cells), and 
many of the R8s that emerge from the MF poorly sustain Sens expression, and thus 
inefficiently recruit secondary (ELAV+) photoreceptors.  A few regions of the eye disc are 
devoid of closely juxtaposed ELAV clusters, as compared to control discs (data not shown).  
These R8s are likely removed by apoptosis, a default fate for uncommitted cells, 
contributing to the ‘rough eye’ of M8-ΔCK2 expressing flies (see Fig. 2A).  
As expression of M8-ΔMAPK and M8-ΔPD with scaGal4 was lethal, we used 109-
68Gal4 to enable analysis of those two M8 variants.  In contrast to M8-ΔCK2, discs 
expressing the M8-ΔMAPK and M8-ΔPD display the inconsistent maintenance of Sens 
levels along the AP axis in a greater proportion of R8s (Fig 3B, C).  Moreover, significant 
regions of the eye disc altogether lack Sens+Elav clusters, a result consistent with the 
reduced eye (Fig. 2B, C).  Thus the reduced eyes of the variants described in Fig. 2 reflect 
defective birth, delayed differentiation and survival of R8s, and impaired secondary 
photoreceptor recruitment.  It is possible to deduce from the severity of R8 defects as seen 
from the three different deletion variants, that M8-ΔCK2 likely acts as a ‘sink’ for modification 
by other kinases, which is required for repressor activity of M8.  As seen in R8 specification 
defect with M8-ΔPD, the need for those modifications are bypassed, which reflect in severe 
deformity of the R8 and secondary photoreceptor clusters.   
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In addition to the reduced eye, all three M8 deletion variants display a strong loss of 
MC’s and mc’s on the thoracic and scutellar regions.  This reflects studies showing both 
scaGal4 and 109-68Gal4 enhancer trap lines are active in the bristle PNC’s.  We quantified 
the MC loss in the heminotum region for all three-deletion variants.  The severity of 
attenuation of MC’s for M8-ΔCK2 with scaGal4  (Fig. 3A’) is comparable to the loss elicited 
by M8-ΔMAPK and M8-ΔPD when driven by 109-68Gal4 (Fig. 3B’, 3C’).  The loss of mc’s, 
however, showed less severity when driven by 109-68Gal4 as compared to scaGal4.  The 
lack of effects on the mc’s reflects weaker strength of 109-68Gal4.  Together, these studies 
reveal that the P-domain is important for M8 activity in the eye as well as bristle formation. 
The effects of M8-ΔCK2 are sensitive to altered EGFR levels 
 Studies described in Chapter 2 implicated the importance of MAPK site in regulating 
repressor activity of M8 during lateral inhibition.  This raises the possibility that M8 may be a 
target of activated EGFR signaling during R8 specification.  If that is the case, then it is 
expected that the retinal defect of the M8-ΔCK2 variant should be sensitive to altered EGFR 
dosage, whereas the M8-MAPK and M8-ΔPD variants should be refractory to changes in 
EGFR signaling as the MAPK site is already compromised in those two variants. 
For this analysis, we used egfrf24, a loss of function (amorphic) allele, which does not 
perturb the eye/R8s in the heterozygous state (data not shown) but is lethal when 
homozygous.  If EGFR pathway indeed regulates the activity of M8, then a decrease in its 
level should attenuate the level of active MAPK, and result in hypo-phosphorylation of M8 at 
its MAPK site.  As mentioned earlier, in such a condition (egfrf24/+ background) the reduced 
eye phenotype of M8-ΔCK2 should be suppressed.  This prediction bears out as we see that 
the severity of reduced eye of M8-ΔCK2 in an egfrf24/+ background is indeed significantly 
attenuated when compared to its effects in egfr+/+ background (Fig. 4A).  This result is 
supported by the qualitative analysis of the eye disc, which shows a strong suppression of 
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the R8 defects in an egfrf24/+ background (Fig. 4A’) in comparison to the strong loss of 
patterned R8s (Sens+ cells) as seen in egfr+/+ background (Fig. 3A). 
A similar analysis was conducted with the M8-MAPK and M8-ΔPD variants, but 
utilized the driver 109-68Gal4 due to lethality upon expression with scaGal4 (see Fig. 2 
inset).  The severity of perturbation of eye defect due to overexpression of these two 
variants was indistinguishable in egfr+ versus egfrf24/+ backgrounds (compare between Fig. 
2B,C and Fig. 4B,C).  Staining of the eye disc with Sens and ELAV display similar neural 
hypoplasia reflecting loss of founding R8’s as seen in an egfr+ background (compare Fig 
3B,C and Fig. 4B’,C’).  Based on this data it can be hypothesized that the two closely 
clustered kinase sites, MAPK and CK2, may participate in ‘cis’-inhibition of M8.  Since this 
interaction is lost when the entire P-domain is deleted, the protein bypasses the necessary 
post-translational modifications and is presented as a prematurely activated repressor.       
M8-CtD strongly suppresses the eye and bristle defects of all the deletion variants 
 It has been previously reported that co-expression of the 56 residue peptide from M8 
(M8-CtD) rescue the reduced eye and bristle defect of M8-S159D (Kahali et al., 2010b).  
Besides recovery of the eye size, it was also shown that co-expression of M8-CtD 
significantly restored the hexagonal facet phasing and the position of the IOB’s.  Importantly, 
rescue does not involve competition between two UAS-constructs for a limiting amount of 
Gal4 protein, because no rescue of 109-68Gal4>M8-S159D was evinced upon co-
expression of UAS-LacZ (data not shown).  We therefore tested for rescue of the reduced 
eye of all the deletion variants by co-expressing CtD peptide of M8.  Indeed, co-expression 
of M8-CtD rescued the reduced eye of M8-ΔCK2, M8-ΔMAPK and M8-ΔPD (Fig.5 A, B, C).    
It also significantly restored the position of IOB’s (data not shown).  M8-CtD largely restored 
the eye field of M8-ΔCK2, almost close to the WT eye, whereas restoration of M8-ΔMAPK 
and M8-ΔPD was also significant.  
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 In addition to the reduced eye, deletion variants also displayed strong loss of the four 
scutellar MC’s (Fig. 3), because the enhancer traps, scaGal4 and 109-68Gal4 are active in 
the bristle PNC’s (Kahali et al., 2009a; Powell et al., 2004).  We wanted to assess whether 
this neural defect is modulated by co-expression of CtD-peptide.  Indeed, our result shows 
that co-expression of M8-CtD peptide restored ~2 scutellar MC’s in each of the deletion 
variants (Fig. 5E).  It therefore appears that co-expression of M8-CtD peptide can effectively 
suppresses both the eye and the bristle defects of the ectopic deletion variants.  The 
possible explanation for such rescue may be the result of binding of the ectopic M8-CtD (in 
‘trans’) to the non-inhibited deletion variants and impairing repression. 
P-domain in M8 may be a target for modulation by Slmb 
Recently, a Drosophila protein-protein interaction screen has revealed Slmb to be an 
interacting partner of M8 (Guruharsha et al., 2012).  Slmb, a subunit of the E-3 ubiquitin 
ligase, interact with phosphorylated Ser residues mark the protein for proteasomal 
degradation.  Detailed sequence analysis of the CtD of M8 indicates that phosphorylated 
Ser residues at 154-159 may create a consensus for Slmb binding.  
We thus tested if Slmb has any effect on the deletion variants by asking whether co-
expression of UAS-Slmb modulates their reduced eye effect.  The reduced eye of all the 
deletion variants upon co-expression of UAS-Slmb (Fig. 6A’, B’, C’) appeared similar to that 
in its absence (compare with Fig. 6A, B, C).  This is result supported by quantitative analysis 
of eye size (Fig. 6D).  The eye sizes in the presence of ectopic Slmb were statistically similar 
to those in its absence.  This suggests that an Slmb cannot target M8 in absence of its P-
domain.  The deletion of the CK2 motif takes out one of the target pSer residues for Slmb 
interaction, which thus fails to interact with the protein and cannot mark it for proteasomal 
degradation.  Since, the pSer residue at the MAPK motif is not a target for Slmb binding, it 
was expected that co-expression of Slmb will rescue ectopic M8-ΔMAPK eye defect.  But 
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our predictions did not bear out (compare Fig. 6B and 6B’).  We think that dually 
phosphorylated M8-CtD (Ser 151+159) serve as a template for hierarchical modification of both 
Ser154 and Ser155, by CK1 and GSK3 respectively, forming a consensus for Slmb target.  
Since M8-ΔMAPK is missing Ser151, the following Ser residues cannot be phosphorylated, 
which then fails to generate Slmb phosphodegron.  In summary, we think that an intact P-
domain is essential for Slmb target of M8 and its subsequent degradation. 
Discussion 
The activities of E(spl) proteins are vital for mediating the effects of inhibitory Notch 
signaling via lateral inhibition.  Therefore it is important to understand the underlying 
mechanism of regulation of E(spl) proteins during neural repression.  Previous work from our 
lab has demonstrated that the CtD of M8 plays a definite role in autoinhibition of the protein 
to prevent its precocious activation (Kahali et al., 2010a).  It has been shown that CK2 
kinase phosphorylates a specific Ser residue in the CtD, which perhaps sets the protein in 
an active state when it can bind and antagonize Atonal during R8 specification (Karandikar 
et al., 2004).  Further studies, as discussed in Chapter 2 suggest that phosphorylation of M8 
by CK2 more likely acts as a conformational ‘gatekeeper’, and that modification by a second 
kinase, the MAPK acts as a final activating switch.  In a sense, CK2 and EGFR together 
may therefore control when and where M8 activity manifests in the developing retina.  The 
putative role of EGFR in regulating M8 activity was strengthened as our studies show that 
the phosphomimetic variants of M8 were responsive to altered EGFR levels (see Chapter 2).  
The above data compelled us to look closer and analyze the role of CtD in autoinhibtion of 
M8 during neurogenesis.  Sequence analysis of the CtD of M8 revealed invariant Ser 
residues upstream of the CK2 motif across all the twelve Drosophila species, that diverged ~ 
50x 106 years (myr) ago.  The remarkably conserved stretch of Ser residues in the CtD has 
been aptly termed the P-domain (phosphorylation domain) as it may be targeted by other 
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kinases.  The P-domain of M8, M5 and M7 are the only conserved region in the CtD, which 
is otherwise variable in length and sequence between the different members.  A similar P-
domain is also present in human HES6, which has been shown to be regulated by CK2 in a 
manner akin to M8 (Gratton et al., 2003a).  Although the developmental consequences of 
phosphorylation of the other Ser residues in the P-domain of HES6 are presently unknown, 
it provides us a window of opportunity to investigate and understand the role of P-domain in 
autoinhibition. 
The studies we present here directly test the role of P-domain in autoinhibition model 
in two relevant developmental contexts, the eye and the bristle.  We have provided multiple 
lines of evidence that the P-domain, which has conserved Ser residues, undergoes 
modifications by different kinases to relieve autoinhibitory effects on M8.  In addition, the 
phosphorylated P-domain is suspected to play a role in formation of ‘phosphodegron’, which 
is a necessary step for protein degradation and clearance. 
Our first line of evidence that P-domain may be involved in repression of M8 comes 
from our deletion variant studies. If CtD autoinhibits M8 in a phosphorylation-dependent 
manner one might expect deletion of the CK2 motif should render M8 hyperactive.  Indeed, 
M8-ΔCK2, which lacks just the CK2 consensus site (S159DCD) (Fig.1), perturbs the eye, but 
only in a stage-specific manner.  It elicits a reduced eye when expressed at stage-2/3 of the 
MF (Fig. 2), but fails to do so at stage-1 (Fig.1).  The inactivity of M8-ΔCK2 at stage-1 
reveals that this protein is not constitutively active, raising the possibility that it requires 
additional conformational modifications, which may occur at stage-2/3.  The presence of a 
consensus MAPK site in the CtD could provide a means for full activation of M8 by 
EGFR/MAPK signaling at stage-2/3 of MF.  To understand the role of the MAPK motif and 
the P-domain in autoinhibiton, the deletion variants M8-ΔMAPK and M8-ΔPD were 
overexpressed in a similar manner at stage-1 and stage-2/3 of the MF.  The MAPK and P-
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domain deletion variants both perturb the eye at stage-2/3 of the MF (Fig. 2).  These are in 
accordance with the theory that due to the deletion of the kinase-specific motifs, the proteins 
can by-pass the need for post-translation modification and act as a repressor and suppress 
Ato immediately.  The overexpression of M8-ΔMAPK variant also elicits eye defect at stage-
1 of the MF.  The most parsimonious interpretation for such a result is that perhaps M8-
ΔMAPK, which is already in a hyperactive state, can precociously repress Ato, even at 
stage-1 of the MF (Fig. 1) where Ato levels are lowest.  If the mechanism of autoinhibition is 
dependent on phosphorylation then overexpression of M8-ΔPD at stage-1 should have 
elicited more severe eye defect.  Unfortunately, analysis of M8-ΔPD at stage-1 did not bear 
out owing to its embryonic lethality (Fig. 1). 
Secondly, the rescue of the severely reduced eye of the M8 deletion variants by CtD-
peptide, an ectopically expressed subdomain of M8, points to the fact that indeed the P-
domain is part of the contact-dependent regulatory mechanism between the HLH and/ 
Orange domain and the CtD of the protein.  It would therefore seem to be the case that the 
ectopically expressed CtD peptide binds (in ‘trans’) to the non-inhibited deletion variants and 
attenuates their interaction with Ato.  Consequently, Ato level would rise to a specific 
threshold to confer the R8 fate, which would increase eye size (facet numbers), as seen in 
our result (Fig. 5).   
Additional role of P-domain in M8 degradation can be speculated from Slmb 
overexpression studies.  The region between the MAPK and CK2 consensus motifs has two 
conserved Ser residues.  A bioinformatics study revealed that these two residues could be 
targeted for modifications by CK1 and GSK3.  A large -scale Drosophila protein-protein 
interaction in S2 cells revealed M8 as an interaction partner with Slmb (Guruharsha et al., 
2012).  Hence, it is of interest to note that phosphorylation of the additional Ser residues is 
predicted to generate a strong site for Slimb/β-TrCP binding, which can then promote 
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proteasomal degradation for M8, providing a possible mechanism for clearance of M8 from 
the MF.  A study in our lab revealed that co-expression of Slmb can rescue the reduced eye 
phenotype of ectopic M8-S159D, a CK2 mimic of M8 (Majot and Bidwai, personal 
communication).  The most parsimonious explanation is, since the additional Ser residues in 
the P-domain of M8-S159D are intact, they can undergo modifications by CK1 and GSK3, 
generating the Slmb phosphodegron, leading to the subsequent removal and clearance of 
ectopic M8-S159D.  If this same logic were applied in case of the deletion variants, one 
would think that the perturbation of eye displayed by M8-ΔPD, which does not have the 
target Ser residues for Slmb binding, will not be rescued by Slmb overexpression. Indeed 
that is the case.  The eye defects of M8-ΔPD cannot be modulated by co-expression of 
Slmb (Fig. 6).  In addition we see similar results with M8-ΔCK2 and M8-ΔMAPK.  This would 
suggest that a hierarchical phosphorylation is needed to generate a putative Slmb-binding 
site and since both these deletion variants are missing one of the consensus motifs for 
phosphorylation, it may disrupt subsequent modifications of the remaining Ser residues, 
leading to impairment of Slmb binding and generation of a stable phosphodegron. 
Our studies indicate that the P-domain in M8 has two modes of action.  The first one 
is to autoinhibit bHLH and/Orange domain through intramolecular binding, thus preventing 
inappropriate association with Ato.  This theory is in concordance with the activity of M8*, a 
protein which lacks the CtD and elicits eye defect when ectopically expressed.  Similar eye 
defects are not mimicked by expression of full length M8, which strongly suggest that the 
truncation triggers the dominant behavior.  Thus, it is imperative that M8 must have an intact 
P-domain to elicit autoinhibitory effects.  Second mode of action is to provide a mechanism 
for rapid clearance of the protein after it has repressed Ato during lateral inhibition.  Based 
on the various modifications the P-domain in CtD undergoes, an epistatic model for 
regulation of M8 through multisite phosphorylation has been suggested (Fig. 8).  As 
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mentioned earlier, dual phosphorylation of M8 by CK2 and MAPK sets the protein in an 
active state, which can then repress Ato.  Phosphorylation of the residues 159 and 151 by 
CK2 and MAPK respectively, may prime M8 for progressive phosphorylation at residues 154 
and 155.  Previous work from our lab has suggested that phosphatase PP2A can 
dephosphorylate M8 at Ser 151 and controls rapid inactivation of the protein (Bose et al., 
2014).  Slmb can target the other three phosphorylated residues in P-domain (154, 155 and 
159) facilitating ubiquitinylation and proteasomal degradation (Fig. 8).  This tandem 
employment of PP2A and Slmb provides a mechanism for rapid reduction in E(spl) activity.  
Endogenous M8 is non-functional at stage-4 of the MF as R8 specification is complete by 
then.  If so, the deletion variants should have no effect at stage-4 of the MF.  But our studies 
reveal otherwise.  The deletion variants effect eye development even at stage-4 of the MF 
(Fig. 7).  It is possible that the deletion variants lacking the consensus Ser residues for 
formation of Slmb phosphodegon are not targeted for proteasomal degradation and 
subsequent rapid clearance and thus remain in the MF even after their inhibitory effects 
during R8 specification has been realized.  It is quite likely that these ectopic deletion 
variants are targeting other proteins in the secondary photoreceptor specification pathway 
and eliciting perturbation of the eye, as we see in our data.  This mode of control via 
phosphorylation followed by rapid inactivation and/or clearance provides a mechanism for 
control of M8 activity levels during R8 specification.  
Future studies to identify the site on the HLH or Orange motif/residues mediating this 
interaction with P-domain will be required to fully reveal the mechanism(s) of regulation of 
M8 during neural repression.  The relevance of this mechanism to other E(spl) members will 
define the ‘qualitative’ difference between them and also help understand the mechanisms 




Materials and Methods 
 
Construction of M8 deletion variants: Three M8 deletion variants were generated by 
inverse-PCR.  M8-ΔCK2 variant harbors the deletion of the CK2 motif (S159DCD), M8-
ΔMAPK variant is missing the MAPK (P149LSP) motif and M8-ΔPD variant is missing the 
entire P-domain (P149LSPASSGYHSDCD).  All the three deletion constructs were amplified 
by PCR using custom forward and the reverse primers incorporating EcoRI and BamHI sites 
5’ and 3’ to the coding region, respectively.  The forward primer incorporated a KOZAK 
consensus (CAAC) immediately 5’ to the ATG codon for efficient expression.  All constructs 
were fully sequenced to confirm the presence of only the intended mutations.  
Germ line transformation: For in vivo expression, all the three deletion constructs were 
cloned into pUAST.  Transgenic lines were generated using a commercial embryo injection 
facility (BestGene, Inc.).  w+ progeny were identified and the location of the insertion sites 
for the different variants were mapped by standard approaches using chromosomes 
harboring dominant visible markers.  At least 10 independent insertions of M8-ΔCK2, M8-
ΔMAPK and M8-ΔPD were generated, and of these ≥5 have been used in the studies. 
Biochemical analysis:  Protein-protein interactions were analyzed by the LexA-based 
version of the yeast interaction trap (Gyuris et al., 1993).  The bait and prey constructs were 
expressed as C-terminal fusions with DNA-binding domain of LexA and the activation 
domain (AD) of B42, respectively.  The yeast strain EGY048p was used to evaluate protein 
interactions, as described (Trott et al., 2001).  LacZ activity was determined for at least three 
independent transformants, each in triplicate.  
Fly stocks: The Gal4 drivers were obtained from Bloomington Stock Center (denoted by the 
prefix B).  These drivers are 109.68Gal4 (B6479), hH10 Gal4 (Huang and Fischer-Vize, 
1996), scaGal4 (Giebel and Campos-Ortega, 1997).  The DER mutant line egfrf24 (B6500) 
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was also obtained from Bloomington Stock Center.  UAS-Slmb flies were obtained from 
Bloomington Stock Center. 
Eye and bristle phenotypes:  All crosses were performed on standard Yeast-Glucose 
medium at 24°C, unless indicated otherwise.  Fly heads were dehydrated by sequential 
passage through a graded alcohol series for 24 hours each (25%-50%-75%-100%), and 
finally passed through Hexamethyldisalinaze.  Heads were mounted on EM stubs, dried for 
24 hours, sputter coated with gold and examined with a JEOL-6400 scanning electron 
microscope at an accelerating voltage of 10-20kV.  Images were processed with Adobe 
Photoshop and collated in Adobe Illustrator.  The reduced eye was quantified from ~20 adult 
flies that were photographed using a Leica MZ16 stereomicroscope equipped with a Leica 
DFC-480 digital camera.  Facet numbers were counted from TIFF images.  A similar 
approach was used to determine bristle phenotypes.  Eye size (facet counts) and bristle 
defects were statistically analyzed using Student’s T-test. 
Immunostaining and confocal microscopy:  Eye imaginal discs were isolated from late 
third instar larvae and processed as described (Kavler et al., 1999) with minor modifications.  
After isolation, discs were fixed in 4% paraformaldehyde in 1x phosphate buffered saline 
(PBS) for 45 minutes at 4°C.  After fixation, discs were washed three times with PBS 
containing 0.3% Triton X-100 (PBS-TX) for 15 minutes each.  The discs were incubated for 
12-14 hours at 4°C in PBS-TX containing primary antibody.  The following antibodies were 
used; guinea pig anti-Sens (gift from Hugo Bellen, HHMI-Baylor) at a dilution of 1:2000 and 
mouse anti-ELAV (DSHB, Iowa) at a dilution of 1:1000.  Following primary antibody binding, 
eye discs were washed three times with PBS containing 0.3% Triton X-100 and then 
incubated with secondary antibody at room temperature for 2-3 hours.  The secondary 
antibodies (Molecular Probes) used for are, goat anti-guinea pig-IgG coupled to Alexa Fluor 
633 (1:1000) and goat anti-mouse-IgG coupled to Alexa Fluor 488 (1:1000).  The discs were 
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mounted in 60% glycerol, and viewed on an Olympus FluoView (FV100) for confocal 
imaging.  Images were acquired every 1um along the apicobasal axis of the discs and then 
compressed as a Z-stack without the removal of any layers.  Compressed Z-stacks were 











Fig. 20: Deletion variants and their MF specificity.   
(A) The functional domains of E(spl)-M8 are represented by a basic domain (DNA binding), 
an HLH domain (dimerization), a second HLH region, the Orange domain (interaction with 
Ato/ASC) and a C-terminal WRPW motif (Gro-binding).  Schematic representation of the 
random deletion mutations of M8 used for the study.  M8-ΔCK2 lacks the CK2 motif, M8-
ΔMAPK lacks the MAPK motif and M8-ΔPD lacks the entire P-domain. (B) Two-hybrid 
interaction of the M8 deletion variants with Gro (co-repressor) was measured as Lac Z 
activity.  (C) Overexpression of M8-ΔCK2 fails to generate any eye defect at stage-1 of the 
MF.  (D) M8-ΔMAPK perturbs the eye at stage-1 of the MF.  Note that any study at this 
stage with M8-ΔPD was precluded owing to embryonic lethality (EL).  (C’,D’)1000x 
magnification of the corresponding genotypes in panels (C-D).  (E) Ommatidial (facet) 




Fig. 21: Deletion variants enhance M8 activity at stage-2/3 of MF.   
(A-C) Adult eye phenotypes of different M8 deletion variants at stage-2/3 of the MF.  
Overexpression of M8-ΔCK2 with scaGal4 perturbs the eye.  Note that overexpression of 
M8-ΔMAPK and M8-ΔPD with scaGal4 leads to EL (embryonic lethality) owing to which the 
study was performed with 109-68Gal4.  Magnification is at 200x.  (A’-C’) 1000x 
magnification of the corresponding genotypes in panels (A-C).  There are extra no IOBs for 
specified for M8-ΔCK2 (A’), whereas, both M8-ΔMAPK (B’) and M8-ΔPD (C’) shows missing 
as well as extra IOBs.  (D) Ommatidial (facet) counts were determined in ≥25 of the 





Fig. 22: Perturbation of R8 birth and differentiation and bristle formation at stage-2/3 
of MF. 
Eye disc of the aforementioned genotypes were immunostained with α-Sens (magenta) and 
α- ELAV (green) to determine R8 differentiantion and secondary photoreceptor recruitment 
respectively (A-C).  Arrow indicates direction of MF progression.  Note that all three-deletion 
variants show random patches of non-specified and non-differentiated retinal tissue at 
stage-2/3 of the MF.  (A’-C’) The deletion variants elicit loss of macrochaetes (MC’s) and 
microchaetes (mc’s) with similar potency.  These effects on the MC’s/mc’s reflect expression 





Fig. 23: Decreased level of EGFR rescue reduced eye of M8-ΔCK2 only.   
(A) Overexpression of M8-ΔCK2 at egfrf24/+ background restores the eye field.  
Overexpression of (B) M8-ΔMAPK and (C) M8-ΔPD at stage-2/3 of the MF at egfrf24/+ 
background fails to restore the eye field.   (A’-C’) Eye discs of genotypes indicated in A,B 
and C were immunostained with α -Sens (magenta) and α - ELAV (green) to assess R8 
differentiation and secondary photoreceptor recruitment.  Facet count was determined in 
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≥25 flies.   Data labeled A, B and C corresponds to the adult eyes shown in panel (A-C).  
Asterisk denotes P-values< 0.001.  Note that the data was compared to eye facet count of 





Fig. 24: M8-CtD suppresses the eye and bristle defects of deletion variants.   
(A) Schematic representation of the functional domains of M8 and M8-CtD.  The C-terminal 
domain (CtD) peptide encompasses residues 123-179 of full length M8 and harbors the 
entire P-domain with intact MAPK and CK2 phosphorylation sites along with the terminal 
Gro-binding site.  (B) Rescue of the reduced eye of scaGal4> M8-ΔCK2 upon co-expression 
of the CtD.  Magnification is at 200x.  (C-D)  Rescue of the reduced eye of 109-68Gal4> M8-
MAPK and 109-68Gal4> M8-PD upon co-expression of the CtD.  (E) Ommatidia facet 
counts were determined in ≥25 of the indicated genotypes.  (F) Suppression of the MC 
defects of the different genotypes upon co-expression of the CtDs.  Numbers to the right 






Fig. 25: P-domain in M8 may be a target for modulation by Slmb. 
Scanning EM of the adult eye at 200x magnification (A-C).  Reduced eye phenotypes of the 
deletion variants at stage-2/3 of the MF.  (A’-C’) Co-expression of Slmb fails to rescue the 
reduced eye phenotype due to overexpression of  (A) M8-ΔCK2, (B) M8-ΔMAPK and (C) 
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M8-ΔPD.  Graph shows ommatidial (facet) counts of the adult eyes. Facet counts were 






Fig. 26: Deletion variants perturb the eye at stage-4 of the MF.   
Scanning EM of the adult eye at 200x magnification.  The adult eye of the deletion variants 
expressed at stage-4 of the MF with gmrGal4.  (A) The M8-ΔCK2 variant shows a rough eye 
phenotype whereas M8-ΔMAPK (B) and M8-ΔPD (C) both shows severely reduced eye.  
Graph shows ommatidial (facet) counts of the adult eyes. Facet counts were determined in 
≥20 flies.  (A’-C’) 1000x magnification of the corresponding genotypes in panels (A-C).  All 
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three variants show ‘blueberry’ phenotype represented by ‘sunken’ ommatidia.  M8-ΔCK2 
(A’) shows a more muted phenotype as compared to M8-ΔMAPK (B’) and M8-ΔPD (C’) 




Fig. 27: Epistatic model of M8 activity in the MF. 
Model shows the P-domain of M8 with conserved Ser residues (in green).  The four Ser 
residues are phosphorylated in an epistatic manner.  The Slmb protein recognizes the 
phosphorylated Ser residues at 154, 155 and 159.  Inset shows consensus motif for Slmb 
recognition.  The schematic representation of different states of M8 has been shown.  At 
autoinhibited state, P-domain blocks HLH and/Orange domain.  MAPK and CK2 
phosphorylation sets the protein at an active state, followed by additional modulation by CK1 
and GSK3.  M8 can then be rapidly inactivated by dephosphorylation by PP2A and finally 
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